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ABSTRACT 
Due to the genomic and epigenetic instability of cancer cells, tumors are highly 
heterogeneous and difficult to treat. Additionally, cancer metastasis, which account for 90% 
of cancer mortality, is a complicated multi-step process. As such ideal assays should be 
high-throughput and provide single-cell resolution and microenvironmet control, 
enlightening individual cell properties rather than the average behavior of the bulk tumor.  
Here, we have developed microfluidic platforms meeting these requirements to investigate 
three critical stages of metastasis.  
First, a single-cell migration chip was developed to model cancer cell migration 
from the primary tumor. The motility of cells under the influence of chemo-attractants can 
be measured on-chip. After the assays, highly motile cells and non-motile cells can be 
retrieved for further culture and analysis. Second, to understand cell survival in the 
circulatory system, a single-cell suspension culture chip was developed, improving the 
throughput of single-cell anoikis assays and single-cell derived sphere formation by orders 
of magnitude utilizing hydrodynamic single cell positioning. Third, to investigate 
interactions between cancer cells and stromal cells, three cell-cell interaction platforms 
were developed. Innovations including control of interacting cell ratios, valveless isolation 
of co-culture using two-phase flow, continuous nutrient renewal enabled by 3D integration, 
and dual adherent-suspension co-culture were attained.  
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In addition, a selective single-cell retrieval technique that selectively detaches and 
retrieves targeted single cells has been developed for incorporation in our microfluidic 
platforms. The technique neither affects cell viability nor alters mRNA expression for qRT-
PCR. These single cell platforms provide numerous advantages over traditional methods 
including: (1) ability to monitor and track individual cells, (2) control of various micro-
environments on-chip for emulation of bio-processes, (3) accommodation of high-
throughput screening, (4) capability to handle rare cell samples, and (5) potential to retrieve 
interesting single cells for further culture and analysis. 
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INTRODUCTION 
This chapter covers the importance of cancer cell heterogeneity and metastasis, the 
motivation of emulating bio-processes in-vitro by single cell microfluidic platforms, the 
goal of the research, and the outline of this thesis. 
1.1 Cancer metastasis 
 
Fig. 1-1. 5-year survival rate of breast cancer with and without metastasis. [4] 
 
Cancer, an uncontrolled growth of cells in vivo, is a leading cause of death in many 
developed countries. However, metastasis, rather than the cancer itself, is the real problem 
[1-4], accounting for nearly 90% of cancer related deaths. In the absence of metastasis, we 
can remove the tumor via surgery in many cases.  In breast cancer, 5-year survival rates 
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drop from 90% to 20% when distant metastases occur (Fig. 1-1) [4]. For this reason, it is 
critically important to investigate and understand mechanisms of metastasis in order to 
improve patient outcomes [5-7].  
1.2 Conventional cancer metastasis assays 
Conventionally, there are two approaches for studying metastasis: xenograft model and 
dish based assays. In xenograft model, cancer cells are injected into the abdomen of the 
mouse and observed to see how they spread in the body [8-9]. This method closely mimics 
the metastatic process in-vivo, but its high cost (around several hundred dollars per mouse) 
and long turnaround time (8 weeks) make it impractical to do large scale screening with 
this method. Though there are a number of dish based assay, the two most common 
approaches to study metastasis are Boyden chamber assays and wound healing assays [8-
9]. In a Boyden chamber assay, cells are loaded on the top of a porous membrane, and their 
invasion through the membrane in traced.  For wound healing assays, cells are removed 
from a small section in a cell monolayer, and their migration and time to migrate into the 
blank region is observed. These assays are low cost (price) and fast (time), but the 
conditions are less relevant to the real in-vivo scenarios. There is a fundamental trade-off 
between physiological relevance and throughput (Fig. 1-3). Xenografts are physiologically 
relevant but low throughput, while the dish based models are high throughput but less 
physiologically accurate. To address this issue, we have created single cell microfluidic 
platforms with both higher throughput and higher physiological relevance than dish based 
models for metastatic studies.  
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Fig. 1-2. The comparison between existing platforms and the proposed single cell 
microfluidic approach. 
1.3 Cancer cell heterogeneity  
In addition to higher throughput and better micro-environment control, single cell 
approaches enable the study of cancer cell heterogeneity. Recently, several studies have 
found significant heterogeneity among cells that were previously treated as essentially 
homogeneous [7]. Still, many assays and measurements are reported as averages over large 
numbers of cells. This assumption that all cells are identical, when they might really be a 
mixture of different cell subtypes, can lead to incorrect or at least imprecise and harder to 
replicate results [7]. Heterogeneity in cell populations poses a major obstacle to 
understanding complex biological processes.  
Due to their genomic and epigenetic instability, cancer cells are highly heterogeneous; 
different sub-populations can have different potential to metastasize and generate new 
tumors [1]. Nevertheless, in the conventional assays, the behavior of small populations will 
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be averaged out, so the results only represent the behavior of the majority.  This is 
especially problematic as cancer relapse and metastasis may be caused by these small sub-
populations in the tumor. To fully characterize the intra-tumor heterogeneity, there is an 
imminent need to develop new technologies for monitoring individual cell behavior in 
well-defined biological and chemical microenvironments. 
1.4 Recent development in microfluidics 
With the development of micro-fabrication, micro-structures fabricated in PDMS have 
proved invaluable for the creation of next-gen cell assays. Although microfluidic 
technology provides better control over microenvironment, higher throughput, and uses 
smaller volumes of reagents, many microfluidic platforms still load hundreds or thousands 
of cells for their assays. Thus, like conventional approaches, they still lack single cell 
resolution [10-18]. Droplet based technology, encapsulating drops of cell solution, can 
easily isolate single cells with very high throughput; [19-21] however, droplet based cell 
culture is not suitable for the study of mammalian cells. First, most mammalian cells are 
adherent cells; therefore, suspension in a droplet can lead to anoikis, resulting in cell 
apoptosis. [22] Second, it is difficult to continuously provide fresh media to each droplet, 
so the nutrition in the isolated droplets deplete over a short period of time. Recently, 
hydrodynamic cell capture schemes have been developed to enable single cell assays [23-
25], but most of them lack precise micro-environment control (e.g. suspension culture, ratio 
controlled cell co-culture environment, isolation and flow control) to recapitulate the 
cancer niche. More importantly, though these single cell assays have the potential to 
investigate the heterogeneity within a tumor or cell line, most studies still treat the cells as 
a homogeneous population.  
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1.5 Research goal of microfluidic platforms 
To facilitate the study of cancer metastasis, which is a complicated multiple-step 
process, we designed three types of platforms (a migration chip, a suspension culture chip, 
and multiple cell interaction chips) to study three main stages of metastasis (Fig. 1-3) [5-
6]. The migration chip is used to study the process of cancer cell migration, from the 
primary tumor to the circulatory system. The single cell suspension culture platform is used 
to study cell survival in the circulatory system. Finally, the cell-cell interaction platforms 
are designed to study the process of secondary tumorigenesis, enhanced by tumor-stromal 
interactions. Utilizing the microfluidic technology, the presented platforms provide five 
key advantages (Fig. 1-4): (1) ability to monitor and track individual cells, (2) control of 
various micro-environments on-chip for emulation of bio-processes, (3) accommodation 
of high-throughput screening, (4) capability to handle rare cell samples, and (5) potential 
to retrieve interesting single cells for further culture and analysis. 
 
 
Fig. 1-3. The three stages of metastasis and the corresponding platforms for studying them. 
[6] 
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Fig. 1-4. Five key benefits of microfluidic single cell platform.  
1.6 Selective cell retrieval for the studies of phenotypic cell heterogeneity  
Conventionally, cell heterogeneity is studied by sorting and characterizing the cells 
with different surface markers using FACS and MACS instruments. Although these tools 
have very high throughput (million cells per hour), the markers used for sorting often may 
not correlate well with the cell behaviors that matter during treatment [26-29]. Using our 
microfluidic chips, we can observe the behavioral heterogeneity of cells, but it is difficult 
to retrieve the cells of interest from the microfluidics for further culture, xenograft, or 
analysis (e.g., mRNA gene expression, epigenome, protein). There are some selectively 
cell retrieval techniques using laser pressure microdissection, vacuum capillary suction, 
localized trypsin exposure, photo degradation of a film substrate, and ultrasound-induced 
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cavitation [30-34], but unfortunately these approaches only work on open substrates. To 
make a selective cell retrieval tool that is compatible with microfluidics, we have 
investigated a photo-acoustic cell detachment mechanism utilizing nano-second pulsed 
laser to detach cells from a CNT-PDMS composite film. The detached cells can then be 
retrieved by precise microfluidic flow control for subsequent analysis. The mechanism was 
proven to have a negligible effect on cell viability and mRNA gene expression.  
1.7 Thesis outline 
The thesis covers two main topics: (1) microfluidic platforms for studying cancer 
metastasis at a single cell level (chapter 2 to chapter 6) and (2) selective cell retrieval by 
photo-acoustic detachment mechanism (chapter 7). The first topic includes the platforms 
that are used to emulate three critical stages of cancer metastasis on-chip, including the 
migration chip (chapter 2), the single cell suspension culture platform (chapter 3), and the 
cell-cell interaction platforms (chapters 4-6). The interaction platforms include cell ration 
control (chapter 4), two-phase isolation and 3D device integration (chapter 5), and dual 
adhesion and suspension culture environment (chapter 6). The second topic describes the 
tool developed for retrieval of interesting single cells from the microfluidic platforms. The 
cell retrieval technology can be and has been applied to the platforms developed in the 
previous chapters. The outline of each chapter is listed below: 
The chapterġ2 introduces !the Single Cell Migration Chip, which can capture cells in 
each capture site and provide a chemical gradient to induce the migration of cells through 
a long capillary channel to model the migration process. The chip is designed to study 
cancer metastasis by measuring the motility and chemo-attraction of cells in an array of 
multiple migration channels. After the assay, the cells can be retrieved for further analysis. 
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Chapter 3 describes the Single Cell Suspension Culture Chip, which can capture 1,024 
cells in an array at a single cell resolution and provide a suspension cell culture 
environment for these cells via polyHEMA coated surfaces that prevent cell adhesion. The 
platform can perform anoikis assays, which evaluate cell survival in suspension 
environment, and single cell derived sphere formation assays, which explore the tumor 
forming potential at a single cell level.  
Chapter 4 covers the ratio controlled cell-cell interaction chip, which can precisely 
control the number of interacting cells and their type to accurately model cancer cell niches 
and provide spatio-temporal control of microenvironments for cell-cell interaction. To 
isolate chambers without using any valves or external pneumatic pumps, we introduced a 
novel actuation method by generating electrolytic bubbles to block the flow. 
Chapter 5 introduces a single cell co-culture platform that implements actuation-free 
isolation using two-phase immiscible flows while providing continuous renewal of media 
through a semi-permeable membrane for long-term co-culture.  
Chapter 6 covers a dual adherent-suspension co-culture device, which can provide both 
a suspension environment for cancer cells and an adherent environment for stromal cells 
in close proximity by selectively patterning polyHEMA in indented micro-wells. In 
addition, the platform specializes in high capture efficiency. Up to 75% of all cells in a 
small samples (50 cells) can be captured, granting the potential to study rare cell 
populations such as primary cells or circulating tumor cells. 
Chapter 7 presents a novel cell detachment technique which provides good spatial 
resolution to selectively retrieve single cells from microfluidic chips. Pulsed laser beams 
were used to generate deformation on a CNT-PDMS composite film on which cells were 
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adhered and cultured. Due to rapid (in milliseconds) deformation, cells can be detached in 
a non-thermal manner. This enables high cell viability and produces a negligible effect on 
the mRNA expression of single cell. 
Chapter 8 concludes the thesis and discusses the future directions in the single cell 
assay chips. 
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SINGLE CELL MIGRATION CHIP FOR HETEROGENEOUS CELL 
POPULATION 
This chapter introducesġthe Single Cell Migration chip, which can capture cells in each 
capture site and provide a chemical gradient to induce the migration of cells through a long 
capillary channel to model the migration process. The chip is designed to study cancer 
metastasis by measuring the motility and chemo-attraction of cells in an array of multiple 
migration channels. After the assay, the cells can be retrieved for further analysis, and the 
cells. 
2.1 Introduction 
Cell migration is an essential process in angiogenesis, cancer metastasis, wound healing, 
inflammation, and embryogenesis. In particular, significant attention has been paid to the 
migration of cancer cells, since cancer metastases account for more than 90% of cancer-
related mortality. [1-3] Cancer metastases result from a multi-step process with significant 
attrition of viable cells at each step in the metastatic cascade. One such step is the 
chemotactic intravasation of tumor cells from the tumor stromal to the capillary bed or 
lymphatic vessels. The response to chemoattractants and migration through these narrow 
microvessels and capillaries are both rate limiting steps for cells traversing through the 
metastatic cascade. The regulation of certain metastasis-related genes can also modulate 
the occurrence and number of metastasis. Although several have been discovered and may 
be potential targets for therapeutics, [4-6] the study of metastasis-related genes still largely 
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depends on xenograft mouse models, which require considerable time and cost and may be 
difficult to adapt to personalized therapy. [7, 8] Single cell resolution and visualization are 
also at present impractical in xenograft-based experiments. Hence, there is an unmet need 
to develop in-vitro devices which can realistically emulate critical steps of the metastatic 
cascade, especially intravasation into and migration through blood and lymphatic 
capillaries. [9] 
Popular approaches for studying cell motility in-vitro such as wound healing and 
Boyden’s assays have significant limitations. [10, 11] Wound healing assays present 
challenges both in the non- repeatability of the execution of the scratch across the plate and 
in its inability to discern the more motile from the less motile cells. [12] Boyden chambers 
provide quantitative binary motility results in large cell populations, but imaging of the 
actual migration process of the individual cells is not possible. These fundamental 
limitations preclude the use of these assays to understand, in detail, the motility of cancer 
cells under conditions that more closely mimic the metastatic cascade. Taking advantage 
of modern microfabrication technologies, a number of recent studies have employed 
microfluidic channels to study cell migration. [13, 14] Different channel cross-sectional 
sizes and geometries have been used to study the effects of geometry on cell migration. 
[15-18] The hydrogel- or extra-cellular matrix was filled within the migration channel to 
simulate the cancer invasion process in the tissue. [19, 20] In some approaches, two or 
more cell types were co-cultured in microfluidic channels to approximate the cellular 
diversity in the tissue micro-environment. [21, 22] However, these previous microfluidic 
approaches which study collective migration behaviors, lack the capability to trace single 
cell behavior and investigate cell heterogeneity in motility.  
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Cellular heterogeneity is a key characteristic of cancer. [23] Due to the genomic 
mutation or epigenetic regulation, [24, 25] each cancer cell has distinct behaviors, including 
cell motility. It is hypothesized that cells that undergo an epithelial-to-mesenchymal 
transition (EMT) can exhibit elavated motility and contribute metastasis. [26-30] Because 
of the importance of motility in metastasis, effective suppression of the EMT has potential 
as a therapeutic strategy. [28-30] As researchers have begun recognizing the importance of 
cellular heterogeneity in metastasis, several papers reported the techniques to study the 
migration behavior at a single cell level. However, these platforms suffer from low capture 
efficiency, loading many cells but only investigating a small portion. This wastes many 
cells, which is unfavorable for applications using rare samples. More importantly, these 
platforms do not allow the retrieval of the cells after migration assay for further 
downstream analysis, preventing understanding of the fundamental causes of elevated 
motility. 
To overcome these limitations, we designed an innovative single cell migration 
platform that incorporates a single cell capture scheme. This scheme positions one cell at 
the entrance of each migration channel, so the migration behavior of each individual cell 
can be easily traced. Using this cell positioning technique, the assays can be performed by 
monitoring 20 captured cells, making the platform favorable for use with primary samples 
and other rare cells. In addition, after the migration assays, both highly motile cells and 
non-motile cells can be retrieved for further downstream analysis. We have demonstrated 
that the highly motile cells selected in the migration assay maintain this behavior off-chip. 
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Lastly, we have demonstrated the capability to customize migration channels, which 
facilitates emulation of lymphatic capillaries for the study of metastasis regulating genes.  
2.2 Design of the single cell capture scheme 
The single cell motility microfluidic device consists of single cell capture sites and 
migration channels. Fig. 2-1 (A) shows a schematic diagram of the proposed chip and 
fabrication processes. To achieve single cell resolution, cells are loaded by gravity flow 
and hydrodynamically captured at each capture site (Fig. 2-1 (B)) by cellular valving. 
Although the hydrodynamic cell capture was previously reported, [33,34] we incorporated 
an capturing design right next to the entrance of a narrow migration channel. As shown in 
Fig. 2-1 (C), two paths are created in the design: a central path and a serpentine path. The 
hydrodynamic resistance of each path is inversely proportional to its flow rate. A long 
serpentine structure increases the hydrodynamic resistance (RS), so the serpentine flow 
resistance is larger than that of the central path. Therefore, the serpentine flow (QS) is less 
than the central flow (QC), and cells will more likely follow the central path. Since the 
opening of the central path is slightly smaller (Height: 20 ȝm, Width: 10 ȝm) than the size 
of cancer cells (e.g., SKOV3 cells has an average diameter of 14.1 ȝm, SD ±3.2 ȝm), the 
captured cell easily plugs the gap and blocks the flow through the central path. Thus, the 
rest of the cells will travel through the serpentine path and will be subsequently captured 
in the downstream capture sites (Fig. 2-2). We simulated the pressure and velocity field for 
various channel geometries (Fig. 2-3). Based on the simulation, we optimized the length of 
the serpentine path to achieve a high cell capture rate. To optimize the cell capture rate in 
this asymmetric capturing design, the media in the right inlet (80 ȝL) is slightly less than 
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that in the left inlet (100 ȝL). The resulting weak flow rightward into the migration channel 
can guide the cells closer to the capture site to increase the capture probability.  
Fig. 2-3 shows the simulation of the pressure and flow velocity under varying 
serpentine lengths ranging from 200 ȝm to 800 ȝm. Ideally, the greater the hydrodynamic 
resistance of the serpentine path (RS) (which is proportional to the serpentine length) the 
higher the capture rate is. However, when the serpentine length is longer than 800 ȝm, the 
hydrodynamic resistance of the serpentine path (RS) becomes so large that the flow velocity 
drops significantly. In this case, cells may get easily stuck along the serpentine path, 
resulting in clogging, which in turn significantly degrades the capture rate. As a result, 
there is a large standard deviation of capture rates observed in chips with long serpentine 
lengths. From these results, the optimal serpentine length was determined, and we have 
achieved high capture rates of over 94% (capturing exactly one cell per each migration 
channel) with a serpentine length of 600 ȝm (Fig. 2-1 (D)). The stiffness of the cells of 
interest is also critical for optimal cell capture. More elastic cells yield higher capture rates 
since they deform more easily and plug the central path, sealing the capture site better than 
stiff cells. Based on the particular cell types used in the experiments, the geometry of 
serpentine lengths and path openings were modified to improve capture efficiency, as 
described in the supplementary methods. Extensive studies have been done on various cell 
types including SKOV3, A2780DK, C2C12, MDA-MB-231, and PC3 cells, and we have 
achieved a capture rate higher than 85% in all the tested cell types (Table 2-1). This 
experimental data demonstrate that the proposed single cell capture mechanism is reliable 
and robust for a broad spectrum of cell types, and thus amenable to the study of cancer 
metastases. 
       
15 
 
 
Fig. 2-1. Presented microfluidic chip for single cell migration. (A) 3D schematic drawing 
of the chip. During cell loading, the culture media containing cells flows from left inlet to 
the outlet, and cells are captured in an array of cell culture sites along the left side. After 
cell loading, the left inlet media is replaced by pure culture media, and the chemo-
attractant spiked media is injected into the right inlet. (B) Enlarged 3D schematic drawing 
of one cell capture site. (C) Schematic of the cell capture principle. Two paths are designed 
for single cell capture. The central path has lower hydrodynamic resistance than the 
serpentine path, so the incoming cells will be diverted to and captured at the central path. 
Since the opening of the central path is smaller than the cell size, the captured cell blocks 
the central path acting as a valve. The next incoming cells will flow through the serpentine 
path and get captured in the subsequent downstream capture sites. (D) The capture rate of 
the migration chip with different serpentine lengths. The longer the paths are, the higher 
the hydrodynamic resistance (RS) becomes, which can enhance cell capture by the central 
path. However, when the serpentine length is longer than 800ȝm, the hydrodynamic 
resistance of the serpentine path (RS) becomes too high, and the slow flow may lead to cell 
clogging, which can significantly degrade the capture rate. The optimal length determined 
from these experiments is 600 ȝm. (E) Concentration gradient of chemicals in the 
migration channel. The red line indicates the simulation result by COMSOL 3.5. The blue 
line is the measurement of the fluorescent dye (Fluorescein 5(6)-isothiocyanate, F3651, 
Sigma-Aldrich) intensity in the migration channel, which correlates well with the 
simulation. 
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Fig. 2-2. Simulations of flow velocity before and after capturing one cell by COMSOL 4.3: 
(A) Before cell capture, simulation of flow velocity shows that the higher flow rate through 
the central path, so the cells will more likely follow the central path. (B) After capturing 
one cell, the captured cell plugs the gap and blocks the flow through the central path. Thus, 
the rest of the cells will travel through the serpentine path and will be subsequently 
captured in the downstream capture sites. 
 
 
Fig. 2-3. Simulations of flow velocity and pressure on different serpentine lengths ranging 
from 200 μm to 800 μm by COMSOL 4.3: (A) Simulations of pressure distribution 
illustrates that the quick transition in the capture site leads to a high capture probability 
of single cells at the site. (B) Simulations of flow velocity indicates that when the serpentine 
structure is short, the flow rate through serpentine path becomes higher, which means that 
the cell is less likely to be driven to the capture gap. 
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Table 2-1. Capture rates of five cell lines among four different cell types. The capture rates 
of all five cell lines are higher than 85%. Since the skov3, C2C12 and MDA-231 cells are 
more elastic than A2780DK and PC3 cells, it is easier for them to squeeze into the capture 
site and block the path. Thus, the capture rate of these elastic populations is higher. 
 
 
2.3 Chemical gradient generation 
The migration of cancer cells can be driven by chemotaxis, whereby differences in the 
concentration of growth factors and chemokines can drive tumor cells to intravasate into 
the circulatory system. [35] To emulate this condition, the migration channels (Width: 10 
ȝm, Height: 40 ȝm, Length: 1 mm) are designed to study the movement of cells, and an 
artificial concentration gradient profile is generated by diffusion. [36] To generate the 
chemical concentration profile to induce cell migration, culture media with chemo-
attractants is pipetted into the right inlet, and the serum free culture media (pure DMEM or 
RPMI) is pipetted into the left inlet. Due to the nature of diffusion, the concentration of the 
chemo-attractant in the migration channels increases linearly along the channel from left 
to right (Fig. 2-4). The generated chemical profile projected in the simulation is confirmed 
experimentally using a fluorescent dye (Fluorescein 5(6)-isothiocyanate, F3651, Sigma-
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Aldrich). The fluorescent intensity is measured and plotted in Fig. 2-1 (E). The measured 
fluorescent concentration profile matches well with simulation (COMSOL 3.5), verifying 
that concentration profiles can be successfully generated. Additional simulations were 
performed to investigate whether a migrating cell in the channel can affect the gradient 
profile. A pseudo-cell (10 ȝm width by 10 ȝm height and 40 ȝm length) was added to the 
model to simulate a potentially blocked channel. However, since the channel cross-section 
(10 ȝm by 40 ȝm) is much larger than that of a cell, the gradient is changed by less than 
2% as shown in Fig. 2-5. 
 
 
Fig. 2-4. Simulations of chemical concentration gradient generated in the device by 
COMSOL 3.5. (A) The simulation of the whole chip demonstrates that the chemical 
concentration is uniform from the upstream to the downstream since the diffusion is 
relatively slow. (B) Enlarged view of the first few channels. The simulated concentration 
profile shows the linear chemical gradient is formed in the migration channel. 
Concentrations are shown in color scale with red being 1 M chemokine and blue being 0 
M chemokine. 
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Fig. 2-5. Simulations of chemical concentration profile with and without cell migrating in 
the migration channel. (A) The simulation of the chemical concentration profile with and 
without cell migrating in the migration channel. The cell was emulated by adding a pseudo-
cell (10 ȝm width by 10 ȝm height and 40 ȝm length) on the bottom of the channel to block 
diffusion. The cell was placed at the center (500 ȝm from the left) (B) The concentration 
profile in the channel. (C) Enlarged concentration profile in the channel from 400 ȝm to 
600 ȝm position. Since the channel cross-section (10 ȝm by 40 ȝm) is much larger than 
cell, the cell can alter the concentration by less than 2%. 
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2.4 Single cell migration assay 
Cancer metastases are caused by a multi-step process which begins with the escape of 
tumor cells from the primary tumor and the subsequent intravasation of cancer cells into 
capillary vessels as induced by chemo-attractants. [35] Competition with these chemo-
attractants or inhibition of the receptors for these regulating signals can be potential 
strategies for cancer treatment. [40, 41] The platform presented herein provides the 
capability to investigate putative chemo-attractants and the efficacy of drug treatments in 
inhibiting motility. In order to validate the utility of the fabricated migration chip, we 
demonstrated chemotaxis of SKOV3 cells induced by Hepatocyte Growth Factor (HGF), 
which is a well-known chemo-attractant for many cell types. [42] 
Fig. 2-6 (A, B) illustrates the single cell migration tests in the platform. During cell 
loading, all the captured SKOV3 cells were positioned at the capture sites along the left 
side as shown in Fig. 2-6 (A). The captured cells attached to the substrate within three 
hours, and the cell chemotaxis was monitored over 24 hours at single cell resolution, as 
shown in the Fig. 2-6 (B). After cell loading, the media in the right inlet was replaced with 
media supplemented with 50 ng/mL HGF, which can induce the SKOV3 cell migration. 
[43] Pure media was pipetted into the left inlet, creating a linear concentration gradient of 
HGF. After 24 hours, we observed that more cells migrated to the right side when exposed 
to the HGF concentration gradient, while the control (applying culture media to both inlets) 
did not show any directional migration (Fig. 2-6 (A)). The statistical analysis is plotted in 
Fig. 2-6 (C). This preliminary data demonstrates that the presented single cell platform is 
suitable for the studies of single-cell chemotaxis. 
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Fig. 2-6. Single cell migration assay with HGF as a chemoattractant. (A) The images of 
the single cell migration assay. The upper two images illustrate the cell distribution after 
cell loading. (Cells were loaded from the left channel.) All captured cells are aligned along 
the left side of the migration channels. The lower two images illustrate the cell distribution 
after 24 hours with the same media in both sides (lower left, control) and with HGF of 
50ng/mL added to the right inlet (lower right, stimulated). Compared to the control, the 
HGF induced cells to migrate more to the right. (B) Process of cell migration. First, a cell 
is captured by the hydrodynamic force from the cell solution. After 4-6 hours the cell 
attaches to the substrate and then it begins to move into the migration channel. (C) Result 
of the chemoattractant assay. The graph illustrates the relative ratio of migrated cells (all 
the way to the opposite side) and migrating cells (within the channel) vs. HGF 
concentration. The result confirms that the HGF is a strong chemo-attractant to the skov3 
cells. Data points represent means ± standard deviations (N= 4 devices), * refers to P < 
10-4. 
2.5 Selective cell harvesting for downstream cellular heterogeneity analysis  
Cellular heterogeneity is a key characteristic of cancer, meaning each cell in a primary 
tumor or even a cancer cell line has its own distinct behaviors. The difference can come 
from genomic mutation or epigenetic regulation such as epithelial-to-mesenchymal 
transition (EMT). In our single cell migration platform, we can easily monitor the 
       
22 
 
movement of each single cell, specializing in the studies of cell heterogeneity. After 
performing migration assays, we can selectively harvest both highly motile cells and non-
motile cells for downstream analysis. This capability grants the opportunity to analyze the 
causes of heterogeneity in motility.  
Although MDA-MB-231 is a motile breast cancer cell line, some cells still have higher 
motility than others. Both highly motile and non-motile MDA-MB-231 cells were retrieved 
as illustrated in Fig. 2-7 (A). Fig. 2-7 (B) shows a highly motile MDA-MB-231 cell, which 
had migrated to the serpentine channel in the right side within 24 hours. To selectively 
harvest highly motile and non-motile cells, we flowed trypsin from the outlet to the inlet, 
detaching and directing motile cells to the right inlet, while the non-motile cells that remain 
in the left side, will be directed to left inlet. After 3 minutes of trypsinization in the 
incubator, the cells became rounded, indicating successful trypsinization (Fig. 2-7 (C)). 
After 5 minutes of trypsinization, the target cells were detached, retrieved from the inlet, 
and transported to the 60 mm petri dish for recovery (Fig. 2-7 (D, E)). After 12 hours 
recovery, E-Cadherin and DAPI staining was performed on the retrieved cells. The highly 
motile cell had weaker E-Cadherin expression than that of non-motile cells, indicating 
EMT-like behavior (Fig. 2-7 (F, G)). [28-30] 4 days after the retrieval, the single cells grew 
into distinct colonies containing 30-40 cells (Fig. 2-7 (H, I)). Comparing the colonies 
formed by highly motile cells and non-motile cells, we found that the harvested highly 
motile cells maintain EMT-like morphology even after forming a colony. In that colony, 
cells were mostly elongated and spread wider than those in a colony formed by non-motile 
cells. Significant difference in the colony radius was observed between the two types of 
colonies (Fig. 2-7 (J)), while no significant difference in the proliferation rate was seen 
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(Fig. 2-7 (K)). This validates the larger colony radius was caused by the EMT-like 
morphology rather than higher proliferation rates.  
To examine whether the difference in motility was maintained after cell retrieval and 
culture, single cell migration assays were performed on the retrieved sub populations. 
Although we only have a small (<1,000) number of cell harvested from early (Day 7) 
colonies of sorted cells, our single cell migration chipcan efficiently use such a small 
sample, as only 20 cells are needed for analysis. The descendant cells of highly motile cells 
were still significantly more motile than those of non-motile cells when assayed under the 
influence of a 10% FBS chemotactic gradient (Fig. 2-7 (L)), while no significant difference 
was observed between the descendant cells of the non-motile cells and the unsorted bulk 
cells. These preliminary results demonstrate that the distinct characteristics of sorted cells 
are maintained after the harvesting process, allowing further downstream studies on the 
differences between highly motile and non-motile cells. 
       
24 
 
 
Fig. 2-7. Selective retrieval and downstream analysis of highly motile cells. (A) The 
schematics of cell retrieval. (B) Two highly motile cells, which have migrated through the 
migration channels within 24 hours. (scale bar: 50 μm) (C) After 3 minutes trypsinization, 
the cells became rounded morphology. (scale bar: 50 μm) (D) After 5 minutes 
trypsinization, the cells were successfully detached and flowed to the right inlet. (scale bar: 
50 μm) (E) The detached cell transferred to the 60mm petri-dish. (scale bar: 50 μm) (G) 
E-Cadherin and DAPI staining of non-motile cell after retrieval (scale bar: 20 μm) (H) E-
Cadherin and DAPI staining of highly motile cell after retrieval (scale bar: 20 μm) (H) 
The colony formed by single non-motile cell after 4 days. The cells in the colony tightly 
connected together. (scale bar: 100 μm) (I) The colony formed by single highly motile cell 
after 4 days. The cells maintaining elongated (mesenchymal-like) morphology, and the 
cells spread widely. (scale bar: 100 μm) (J) The comparison of the colony radius between 
highly motile and non-motile cells. The colonies formed by motile cells have significantly 
larger radius. (N = 8 colonies), ** refers to P < 0.01. (K) The comparison of the number 
of cells per colony between highly motile and non-motile cells. No significant difference 
was observed. (N = 8 colonies) (L) The migration distance of single cell migration assays. 
Descendants of highly motile cells still more motile than the descendants of non-motile 
cells and unsorted bulk MDA-MB-231 cells (N = 5 devices), * refers to P < 0.05. 
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2.6 Customized migration channel for emulating lymphatic capillaries 
With the presented platform, we are also capable of customizing the migration channel 
in order to emulate cell migration through various tissues. The lymphatic capillary invasion 
process is a critical step in the metastasis of cancer through to the lymph nodes, so we 
designed narrow channels with choke points to emulate lymphatic capillaries [43]. As a 
further demonstration of the proposed device’s capabilities, we studied a mitogen activator 
of protein kinase (MAPK) family members, p38Ȗ, and its role in breast cancer cell 
migration. The MAPK members, including p38Ȗ, are known to be involved in cell motility 
signaling pathways. Additionally, p38Ȗ mRNA is overexpressed in several types of cancer 
and helps increase Ras-induced cancer invasion. Knockdown of p38Ȗ genes degrades the 
efficiency of lymph invasion in-vivo, partly due to drastically changing the type of motion 
the cell can undergo [45]. It is believed that p38Ȗ knockdown leads to ubiquitination and 
degradation of Ras homology gene family member C (RhoC) [45, 46]. Due to a lack of 
RhoC, the knockdown cells (GKD) are unable to form long pseudopodia and thus engage 
in unproductive cytoskeleton cycling that does not effectively lead to cellular displacement. 
The resulting unorganized cytoskeleton reduces the efficiency of cell movement. To 
characterize the invasion capability of MDA-MB-231 (breast cancer) cells in a 3D model 
of lymphatic capillaries, we designed a single cell migration chip that contains multiple 
migration resistance choke points and successfully demonstrated the capability of tracing 
single cells in this lymphatic capillary invasion assay (Fig. 2-8 (A)). The size variation of 
the migration channels and choke points are illustrated in Fig. 2-8 (B) 
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Fig. 2-8. Customized migration channels for emulating lymphatic capillaries. (A) 
Microphotograph of the fabricated device. The cells are loaded in the left side, and the 
chemo-attractant induces the migration through migration channel to the right. (B) Size 
variation of migration channels. The length of choke point is 100 ȝm, and the width of 
choke point varies from 6 ȝm to 30 ȝm. It is difficult for cells to migrate through the narrow 
choke point, which is similar to the geometry of lymphatic capillaries. Thus, the ability to 
migrate through the narrow choke point can be used to predict the invasion potential. (C) 
Qualitative observation of migration behavior of MDA-MB-231 cells (F-actin is labeled 
by RFP) in the 6 μm x 10 μm choke point. The scrambled (SCR) cells can form a stable 
and long stress fiber to migrate through the choke point, while the p38Ȗ knockdown (GKD) 
cells can only deform into the choke point. (D) Single cell migration assay on different 
channel geometries. We measured the average number of choke points passed by SCR and 
GKD cells for various choke point dimensions with 20% FBS as an chemoattractant. The 
motilities of both cells are similar in the straight channel, but the SCR MDA-231 cells are 
far more motile in the narrow channel. This result predicts the higher invasion potential of 
SCR MDA-231 cells in-vivo. Data points represent means ± standard deviations [N= 8 
devices), * refers to P < 10-5.  
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First, we observed cell migration behavior in the narrow choke point migration 
channels with a choke point of 6 μm x 10 μm. Fig. 2-8 (C) shows the representative 
morphologies of scrambled vector (SCR) cells and p38Ȗ knockdown (GKD) cells. F-actin 
fibers are labeled by RFP red fluorescence. Since SCR cells were able to form long 
pseudopodia past the choke point in a mesenchymal-like manner, the cells were successful 
in migrating through the narrow channel by contraction of the stress fibers in the typical 
“rubber band-like” fashion. Due to the lack of RhoC and other global effects of p38Ȗ 
knockdown, the GKD cells could only squeeze into the narrow channel with the actin 
evenly distributed around the periphery of the cell but could not form pseudopodia. The 
SCR cells are much more mesenchymal in nature whereas the GKD cells exhibit an 
epithelial pattern. Next, we measured the cell migration distance (as a function of “passed 
choke points” or relative distance in the channels) for multiple choke point geometries, as 
shown in Fig. 2-8 (D). Since hepatocyte growth factor (HGF) may also regulate RhoC and 
confound the results, in this experiment, we used 20% serum (FBS) media as the 
chemoattractant [46]. We observed that SCR and GKD cells have a similar motility when 
the migration channel is wide (30 μm x 10 μm) and without choke points, but the motility 
of GKD cells significantly diminishes when the channel is obstructed by narrow choke 
points (6 μm x 10 μm). To verify the lower migration efficiency of p38Ȗ knockdown cells, 
the velocity of MDA-MB-231 cells in the narrowest choke point channel (6 μm x 10 μm) 
is measured and shown in Fig. 2-9. Although the variation is large, the velocity of SCR 
cells is almost double that of GKD cells. This result reaffirms the hypothesis that the 
motility of GKD cells decreases due to a lack of RhoC, which causes unproductive actin 
cytoskeletal cycling. This experiment demonstrates the potential of the proposed single cell 
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platform for studying models of cell migration through geometrically constrained tissues 
and the ability to discern cellular motility differences as a result of gene knockdown. 
 
Fig. 2-9. The migration velocity of MDA-MB-231 cells in the 6 μm x 10 μm choke points. 
The scrambled (SCR) cells can migrate more efficiently than the p38Ȗ knockdown (GKD) 
cells through the choke point.  
2.7 Chapter Summary 
There are many microfluidic devices for cell migration have been reported in recent 
years. Although these works exploit the advantages of microfluidics (small volume and 
precise micro-environment control), most assays still measure the average behavior over 
large numbers of cells with an underline assumption that all cells are identical. This leads 
to incorrect, or, at least, imprecise results. Cell heterogeneity is an important part of what 
makes cancer treatment difficult and complicated. The microfluidic tool presented has the 
potential to distinguish and characterize individual cell behaviors. Here, we demonstrated 
single-cell migration, investigating individual properties of each cell rather than the 
average behavior. After the assays, cells of different motility can be selectively retrieved 
for further downstream analysis.  
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The presented tool can reliably position exactly one cell right next to the channel, 
granting the advantages of using small number of cells and allowing easily tracing of single 
cell migration behavior. We incorporated the hydrodynamic scheme with migration 
channel, so single cells can be positioned right next to the narrow migration channel the 
assays. Through optimization we can achieve 90% capture rates in 5 different mammalian 
cell lines. As only 20 cells need to be monitored for analysis, the assays can be performed 
by small number of cells. In addition, the chemo-gradient profile can be reliably generated 
in the narrow migration channels, and a migrating cell in the channel has limited effect on 
the concentration profile. Using presented platform, we have successfully demonstrated 
three single-cell migration assays: tracing SKOV3 cells chemotaxis induced by HGF, 
studying MDA-MB-231 cancer cell heterogeneity in motility, and studying metastasis-
related genes (p38Ȗ) by evaluating their effect on migration in the artificial lymphatic 
capillaries.  
In addition to single cell migration assays, the platform also provides a method for 
motility based cell behavioral sorting. Highly motile and non-motile cells can be selectively 
retrieved after migration assay, and the retrieved cells were proved to be viable for staining 
and culture. The preliminary results demonstrate that the distinct characteristics of sorted 
cells are maintained after the harvesting process, allowing for further downstream studies 
in the difference between highly motile and non-motile cells. We demonstrated that the 
heterogeneity in a cell line, and the presented platform provides the capability to study this 
heterogeneity and the potential to correlate the motility behavior with the molecular 
signature of single cells. 
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SINGLE CELL SUSPENSION CULTURE USING POLYHEMA COATING FOR 
ANOIKIS ASSAY AND SPHERE FORMATION 
This chapter describes the Single Cell Suspension Culture chip,” which can capture 
1,024 cells in a chip at a single cell resolution and provide a suspension cell culture 
environment for these cells via polyHEMA coated surfaces that prevent cell adhesion. The 
platform can perform anoikis assays, which evaluate cell survival in suspension 
environment, and sphere formation assays, which indicate the tumor forming potential at a 
single cell level within a population.  
3.1 Introduction 
Since metastatic cancer accounts for more than 90% of cancer-related mortality, 
targeting cancer metastases can greatly improve patient prognosis [1,2]. Although 
inhibiting metastatic capacity is critical for successful therapy, pre-clinical studies are 
limited in throughput due to extended time periods and high cost of xenograft models [3]. 
Hence, there is an unmet need to develop in-vitro devices that can emulate aspects of 
metastasis, study critical signaling pathways in metastasis, and test therapeutic 
interventions. Conventional in-vitro assays of metastasis focus on cancer cell migration 
and invasion [4,5], though that only represents the early stages of cancer metastasis1. After 
migration from primary tumors to the circulatory system, cancer cells need to survive in 
suspension and then re-grow into a micro-metastasis once suitable secondary sites are 
reached.  
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 For normal and pre-malignant cells, adhesion to the extracellular matrix (ECM) is 
essential to maintain cellular homeostasis, and disruption of cell attachment leads to anoikis, 
a form of programmed cell death6. In order to successfully metastasize, tumor cells must 
detach from the ECM and maintain their viability in the circulatory system. Most 
circulating tumor cells (CTCs) will die as a result of losing adhesive junctions, so anoikis 
serves as a natural barrier for metastasis [3,7]. Since most CTCs are single cells, studying 
the survival and growth of metastatic cancer cells should be modeled using single cell 
assays [8]. Performing single-cell assays in cell-culture dishes is limited by low-throughput 
and poor reliability. Due to these issues, thousands of cells are used in conventional anoikis 
assays, which assess the cell viability in suspension culture dishes after a few days [9]. 
However, cell aggregation, which inevitably happens, can enhance the viability of cells in 
aggregates, resulting in a skew of survival rates. Although anti-aggregation additives (e.g. 
Heparin) can be used to mitigate aggregation, the anoikis behavior can be significantly 
affected [10]. Another issue in bulk anoikis assays is reliable media exchange. Cells can 
be easily lost when replacing the waste media by pipetting; as a result, the duration of the 
assay can be limited.  
 Due to genomic instability of cancer cells [11,12], certain cells may have a higher 
metastatic potential. For example, tumor-initiating cells (TICs), which are a small portion 
of the whole tumor [13-15], are hypothesized to serve as metastatic seeds and be 
responsible for tumor re-growth following chemotherapy and radiation [16]. However, 
their behavior can be averaged out by bulk tumor cells in conventional assays [17-19]. To 
understand the behavior of each cell in a heterogeneous group, we should be able to provide 
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single cell resolution at high throughput, enlightening individual properties of each cell 
rather than the average behavior of the bulk tumor. 
 There are a number of previous works reporting microfluidic platforms for 
performing sphere assays on-chip, including hanging droplet methods [20-22] and micro-
rotation flow [23]. These platforms accomplished suspension culture resulting in mostly 
cell aggregation rather than single cells. The droplet-based system can isolate single cells 
in suspension; however, it is difficult to continuously provide fresh media to each droplet, 
so the nutrients in the isolated droplet are depleted over time [24]. Recently, we 
demonstrated successful suspension cell culture in our single cell platform by integrating 
topographically-patterned polydimethlysiloxane (PDMS) layers to provide a super-
hydrophobic surface for facilitating suspension cell culture without aid of any chemical 
coatings [25]. Despite its advantages over many conventional suspension culture coatings, 
the patterned surface requires the deep reactive ion etching of silicon in fabrication and 
makes optical imaging complicated.  
 In this work, we report a single cell suspension culture chip, which can provide 
high-throughput of 1,024 assays in a trial, single cell resolution (locating exactly one cell 
into each chamber) and continuous media perfusion to avoid the difficulty in exchanging 
media. To the best of our knowledge, this is the first trial of integrating polyHEMA in a 
single cell platform for single cell anoikis assays. 
3.2 Single cell capture scheme 
For the presented single cell anoikis assay chip, we adopted our previous single cell 
hydrodynamic capture scheme [26]. Fig. 3-1 (A) shows the fabricated device with 1,024 
microchambers, which facilitates high throughput single cell assays. Cells are loaded from 
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the inlet to the array of microchambers. The flow is generated spontaneously by the liquid 
height difference between the inlet and the outlet, so no external pump is required. In each 
microchamber, there are two fluidic paths: the central path and serpentine path (Fig. 3-1 
(B)). The central path has lower flow resistance, so, the first cell entering the chamber tends 
to flow through the central path (Fig. 3-2). As the opening of the central path is smaller 
than the cell size (10 μm by 15 μm) and sterically captures the cell, the captured cell will 
block the central path and act as a valve, increasing the central path resistance. The 
following cells will thus preferentially flow through the serpentine path and be captured in 
the downstream microchambers (Fig. 3-2 (F)).  
 
Fig. 3-1. Microfluidic chip for single cell suspension culture. (A) Photograph of the 
fabricated 1,024-microchamber device, in which the media containing cells flows from the 
inlet to the outlet. (B) Enlarged schematic of a cell capture chamber with a central path 
and serpentine path. (C) Fluorescent micrograph of captured SUM159 cells in the 
fabricated chip, showing a 9 by 9 segment. Cells were stained with CellTracker Green. 
Scale-1000Pm. 
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Fig. 3-2. Simulations of flow velocity and pressure on the cell capture scheme by COMSOL 
4.3: (A, B) Simulations of pressure distribution before and after cell capture. (C, D) 
Simulations of flow velocity before and after cell capture. (E) The simulated flow pattern 
before cell capture. The red arrows indicating flow direction and velocity suggest that the 
cells are likely to be guided to the capture site and get captured. (F) After cell capture, the 
capture cell blocks the flow through capture gap, so the next cell will be guided to the 
serpentine path.   
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Extensive experiments have been performed by five cell types; high cell capture rates 
of > 70% have been achieved in all of these cell lines. Fig. 3-1 (C) shows a 9 by 9 subset 
of the array of culture chambers, in which 70 SUM159 cells were captured    for an 86.4% 
capture rate. The captured single cells can be easily distinguished by optical imaging, 
making this platform ideal for quantifying heterogeneous cell populations. Using this chip, 
we can capture, culture, and monitor nearly 700-800 single cells in a single experiment, so 
the presented system outperforms previous miniaturized anoikis platforms in throughput 
and capture rate by an order of magnitude [27, 28].  
 
3.2 Characterization of PolyHEMA coated substrate  
To achieve suspension culture in our single cell platform, we used poly(2-hydroxyethyl 
methacrylate) (polyHEMA) as a non-adherent coating material [29]. After absorbing water, 
polyHEMA forms many hanging long-chains that block cell adhesion on the substrate. 
Although polyHEMA has been used for suspension culture for more than 30 years, it has 
not yet been integrated with microfluidic technology. Conventional coating techniques are 
very simple: polyHEMA is first dissolved in ethanol, and then the solution is added to a 
cell-culture dish. After natural evaporation of ethanol, polyHEMA will form a thin film on 
the dish [30]. However, due its surface roughness and non-uniformity, this process has two 
major challenges when integrated with microfluidics. First, large surface roughness, 
resulting from uncontrolled evaporation of ethanol, leads to poor bonding with the PDMS 
layer and inducing severe leakage (Fig. 3-3 (A)). Second, due to the non-uniformity of film 
thickness, we need to apply a thicker polyHEMA coating (~ 30 mm) to prevent pinholes 
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or openings in the coating. As polyHEMA can absorb 50% water (w/w) and expand [31], 
the expanded polyHEMA hydrogel can block the fluidic channel thereby preventing ideal 
device operation.  
 
Fig. 3-3. Surface properties of polyHEMA films. 3D surface profile of polyHEMA coated 
substrate by (A) conventional evaporation process or (B) by spin coating and reflow 
process. MDA-MB-231 cells were cultured for 24 hours on (C-E) non-coated glass 
substrate or (F-H) polyHEMA coated substrate. Phase contrast micrographs (C, F) and 
scanning electron micrographs (D, G) of single MDA-MB-231 cells. (E, H) MDA-MB-231 
cells were stained for actin (red), vinculin (green), and nucleus (DAPI blue).  
 
The presented process is composed of two steps: spin coating and reflow. The spinning 
process removes any excess polyHEMA from the surface, and the thickness of polyHEMA 
layer can be precisely controlled by the spin speed. Although the rapid spinning speed may 
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result in quicker evaporation of ethanol, leaving cavities on the surface and some trenches 
along the radial direction, these issues can be alleviated by reflowing the polyHEMA film 
at an elevated temperature after spin coating (Fig 3-3 (B)). As the glass transition 
temperature of polyHEMA is around 100°C, the polyHEMA film can reflow to fill the 
cavities and trenches at a temperature above 100°C and below 200°C, the burning 
temperature of polyHEMA (Fig 3-4). The surface roughness root mean square (RMS) of 
the conventional coating process is more than 3 μm, while that of the spin-coated films is 
less than 0.2 μm (Table 3-1). Compared to the conventional evaporation process, which 
generates high peaks and deep valleys, the thin and uniform polyHEMA films coated by 
the spin and reflow method can reliably bond with the PDMS layers for suspension cell 
culture. 
 
Fig. 3-4. PolyHEMA spin-coated surface with and without reflow process: (A) the 
polyHEMA spin-coated surface without reflow. As the ethanol evaporates fast during the 
spin-coating, the radial trenches are formed on the substrate. Also, some evaporation 
bubbles were trapped in the polyHEMA film, making the surface coarse. (B) After reflow 
at 200 °C overnight, the trench profile was flattened, and the trapped bubbles were 
released, making the coated surface smoother. 
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Table 3-1. The comparison between conventional and presented polyHEMA coating 
technology. Data are shown as the mean ± SD (N = 5), *** P < 10-3.   
 Conventional Spin & Reflow 
Thickness*** 30.5±2.71 μm 2.04±0.26 μm 
Roughness RMS*** 3.15±0.50 μm 0.19±0.04 μm 
Peak Height*** 6.55±0.62 μm 0.56±0.07 μm 
Valley Depth*** 9.24±1.65 μm 0.65±0.14 μm 
3.3 Suspension culture on polyHEMA coated substrate 
After characterizing coating quality, suspension cell culture was performed on the 
coated substrate and compared to conventional culture. MDA-MB-231 breast cancer cells 
cultured for 24 hours on glass substrate without polyHEMA coating exhibit spreading 
morphology and focal adhesions indicating good cell adhesion (Fig 3-3 (C, D)). In contrast, 
MDA-MB-231 cells cultured on the polyHEMA-coated surface indicate no focal adhesions 
formed on the substrate and cells maintained a rounded morphology (Fig. 3-3 (F, G)). Focal 
adhesions serve as the link between internal cytoskeletal networks and ECM. Therefore, 
the absence of focal adhesions indicate whether a cell is truly cultured in a suspension 
environment32. MDA-MB-231 cells were plated on standard tissue culture plastic with and 
without polyHEMA coatings, and their focal adhesions were stained. Cells cultured on a 
normal tissue culture plastic expressed distinct vinculin focal adhesion clusters (Fig. 3-3 
(E)), while cells cultured on polyHEMA did not form focal adhesions (Fig. 3-3 (H)). No 
adherent cells or cells with distinct extracellular vinculin clusters were observed in the 
polyHEMA-coated dishes, confirming a robust non-adherent environment by the 
polyHEMA coating. 
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3.4 Single cell anoikis assay  
While conventional dish-based anoikis assays load many cells and suffer from 
uncontrolled cell aggregation, our approach provides precisely one cell in a chamber (Fig. 
3-5 (A)). We quantified the ability of single C2C12 normal myoblast and SUM159 breast 
cancer cells to survive in adherent or suspension conditions in the microfluidic chip. For 
the normal myoblast cells, adhesion to the substrate is critical for maintaining viability; as 
a result, only 4% of the captured cells survived after six-day culture in suspension (Fig. 3-
5 (B)). However, 50% of SUM159 cells, which is a highly aggressive cancer cell line, can 
survive in suspension. Significant difference in vaibility was observed on day 2, day 4 and 
day 6. 
 Within tumor cells, TICs are an emerging target for cancer therapy due to their 
resistance to conventional drug therapies and potential to initiate relapse of cancer [13, 17, 
33]. Aldehyde dehydrogenase (ALDH) activity is a well-known marker of these cells, 
which are identified using the ALDEFLUOR assay [33, 34]. High ALDH expression in 
tumors correlates with poor patient prognosis [35]. ALDH+ SKOV3 cells are highly 
enriched for tumor-initiation and resistance to chemotherapy [34]. To test if ALDH+ cells 
are more resistant to anoikis, we loaded SKOV3 cells into polyHEMA-coated microfluidic 
chips, and used the ALDEFLUOR assay to identify the ALDH+ cells right after cell 
loading. Following six days of suspension culture, cell viability was assessed by 
LIVE/DEAD staining. 31.2% of the ALDH+ population survived, while the survival rate 
of ALDH- SKOV3 cells was only 9.3% (Fig. 3-5 (C)). This result confirms that ALDH+ 
cancer cells exhibit stronger resistance to anoikis.  
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Fig. 3-5. Single cell anoikis assay. (A) SKOV3 cells were plated in conventional dishes 
(left) or fabricated microfluidic chips (right) that were uncoated (top) or polyHEMA coated 
(bottom). Cells were loaded at 1000 cells/cm2 (left) or at single cell level (right). Cell 
viability (green=live, red=dead) was measured 48 hours later. (B) SUM159 and C2C12 
cells were loaded into uncoated (adherent) or polyHEMA (suspension) microfluidic chips 
and cell viability measured 2, 4 or 6 days later. Data are shown as the mean ± SD (N = 4), 
*** P < 10-3. (C) SKOV3 cells were loaded into polyHEMA coated microfluidic chips and 
stained with the ALDEFLUOR assay to identify ALDH+ and ALDH- cells. Cell viability 
was assessed using the LIVE/DEAD kit at the indicated time points. Data are shown as the 
mean ± SD (N = 6), ** P < 10-2. (D) SKOV3 cells were loaded into uncoated and 
polyHEMA coated microfluidic chips in the absence or presence of 50 ng/mL HGF. Cell 
viability was assessed using the LIVE/DEAD kit at the indicate time points. Data are shown 
as the mean ± SD (N = 9), ** P < 10-2. 
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Anoikis can be regulated through a variety of intrinsic and microenvironment factors 
that play a key role in determining the outcome of metastasis [2]. Hepatocyte growth factor 
(HGF) has been shown to trigger greater resistance to anoikis in cancer cells [36, 37], and 
SKOV3 cells were tested since most cells die in suspension by day 6. In media without 
HGF, only 11% of SKOV3 cells survived for 6 days, while the viability increased to 37% 
when treated with 50 ng/mL HGF (Fig. 3-5 (D)). This experiment confirmed that HGF can 
enhance the resistance of single cells to anoikis and demonstrated the feasibility of our 
platform in screening for regulators of anoikis. 
3.5 Sphere formation from single cells 
Although some metastatic cancer cells can survive in the circulatory system by 
avoiding anoikis and seed secondary organs, the majority of cancer cells remain dormant 
and do not proliferate [2]. Two possible reasons that can explain this phenomenon include: 
1) the survival and proliferation of metastatic cancer cells depends on signals from the 
microenvironment [2], or 2) that only TICs are able grow into a secondary tumor [18, 19]. 
Sphere formation has been suggested as a surrogate assay for stem/progenitor cell activity 
[38, 39]. We assessed the ability of the suspension microfluidic chips to support sphere 
formation by culturing cancer cells in serum-free media supplemented with EGF, FGF, 
B27 and other reagents. For SUM159 cells, 55% of single SUM159 cells can grow to a 
sphere with a size larger than 50μm diameter in 10 days (Fig 3-6 (A-F)). In contrast to 
SUM159 cells, MDA-MB-231 cells have a low proliferation rate in suspension, forming 
small and loosely connected aggregates (Fig. 3-6 (G)). Compared to SUM159 and MDA-
MB-231, MCF-7 breast cancer (Fig. 3-6 (H)) and C6 glioma cells have moderate-sphere-
forming potential (Fig. 3-6 (I)). Around 3% of the captured MCF-7 and C6 can form 
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spheres. In addition to the sphere formation rate (Fig. 3-6 (I)), the size of each sphere can 
be continuously monitored over 10 days (Fig. 3-6 (J)). These experiments demonstrate the 
capacity to perform high-throughput sphere formation assays where hundreds of spheres 
can form in a single assay.  
 
Fig. 3-6. Formation and morphology of cancer spheres derived from a single cell: (a-f) 
The development of a SUM159 sphere from a single cell in the polyHEMA-coated 
suspension culture micro-chamber: (A) day 0, (B) day 2, (C) day 4, (D) day 6, (E) day 8, 
and (F) day 10. (G) The development of sphere formation from single MDA-MB-231 cell 
after ten days. (H) The development of sphere formation from single MCF-7 cell after ten 
days. (I) The sphere formation rates of SUM159, MCF-7 and C6 cells for spheres with a 
diameter larger than 50 μm. (J) The sphere size change of SUM159 over time by the 
diameter of spheres from day 0 to day 10. 
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3.6 Sphere formation rate of stem-like Notch+ and non-stem-like Notch- cells 
As the presented tool can monitor sphere formation of individual cells over time, we 
investigated the cellular heterogeneity in T47D breast cancer cells. The Notch pathway is 
a signaling pathway that regulates cell self-renewal and differentiation, and high Notch 
expression is related to stem-like properties and higher tumor initiating potential [40, 41]. 
To monitor Notch pathway activation, we transduced T47D cells with a lentiviral 
(pGreenFire1) Notch reporter containing multiple Notch response elements upstream of a 
minimal CMV promoter regulating destabilized GFP. Due to asymmetric division, some 
Notch+ cells generate Notch- daughter cells, so the cell culture becomes a mixture of 
Notch+ and Notch- populations. To measure sphere formation from Notch+ and Notch- 
T47D cells, we loaded unsorted cells into suspension microfluidic chips and cultured in 
serum-free media. After culture for 14 days, both Notch+ and Notch- T47D cells formed 
spheres (Fig. 3-7 (A, B), but the sphere formation rate of Notch+ cells was significantly 
higher (Fig. 3-7 (C)). This result confirms that Notch+ cells have a higher 
stem/progenitor cell potential. In addition, the average diameter of Notch+ spheres was 
significantly larger than that of Notch- spheres (Fig. 3-7 (D)), indicating a higher 
proliferation rate of the Notch+ cells. The sphere formation data from T47D cells is 
consistent with the previous rate reported from the conventional sphere assays [41]. This 
experiment validates our capability to study the sphere-forming potential of different 
subpopulations within a heterogeneous cell population. 
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Fig. 3-7. Differential cancer sphere formation from Notch+ and Notch- T47D cells. 
Representative cancer sphere derived from a single (A) T47D Notch- (GFP-) or (B) T47D 
Notch+ (GFP+) cell in the polyHEMA coated suspension culture micro-chamber. (C) 
Sphere formation rate of Notch+ and Notch- cells after 14-day culture. Data are shown as 
the mean ± SD (N = 4), ** P < 10-2. (D) Average sphere size of Notch+ and Notch- cells 
after 14-day culture. Data are shown as the mean ± SD (N = 4), ** P < 10-2. 
3.7 Chapter Summary   
We present a microfluidic system for high-throughput single-cell suspension culture 
using a hydrodynamic capture scheme and optimized polyHEMA coating technique. In the 
cell capture experiments, the flow in the microfluidic chamber is consistent with computer 
simulation, and thus single cells were captured reproducibly in the array of 1,024 chambers 
by simple gravity flow without any external component. Among 5 different mammalian 
cell types, high and reliable capture rates from 71% - 84% were attained; the weak 
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sensitivity to the cell type makes the platform a generic single-cell assay tool. Using the 
platform, the cells are individually separated into each chamber; this will not only prevent 
uncontrolled cell aggregation but also enable tracking of individual cell behaviors within 
heterogeneous populations. 
 Although polyHEMA has been used for suspension cell culture, the conventional 
coating technique provides poor uniformity due to its uncontrolled evaporation process. 
The spin-coating, which can achieve a controlled evaporation process and remove 
excessive polyHEMA solution, is widely used in microfabrication, so we introduced it in 
the polyHEMA coating technique. Even though pinholes and trapped bubbles are generated 
during spin-coating, these defects can be removed by double spin-coating and high 
temperature reflow. With the optimized coating protocol, the surface roughness can be 
reduced to 0.2 μm, which is only 6% of the conventional coating process, so the uniform 
coated substrate can be successfully integrated in microfluidics. 
 The features of single-cell, high-throughput, and reliability distinguish the 
presented approach from previous dish-based and microfluidic methods for suspension 
culture. This is particularly important in the study of cancer metastasis. Due to cancer cell 
heterogeneity, each cell has its own unique property, and thus behaves differently in 
metastasis. Still, most assays measure the average cancer invasion behavior over large 
number of cells with an underlining assumption that all cells are identical, which can lead 
to incorrect, imprecise results. The presented platform facilitates monitoring the behaviors 
of 1,024 heterogeneous single cells simultaneously, so the distribution of individual cell 
behaviors can be analyzed in one assay. As such, we demonstrated different anoikic 
behaviors between stem-like and non-stem-like SKOV3 ovarian cancer cells.  
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 Finally, for single-cell-derived sphere formation assays, which typically take two 
weeks or longer, the reliable media exchange is an important issue, because cells in 
suspension can be easily lost when replacing the waste media by pipetting. In contrast, the 
presented platform provides a continuous perfusion of media from gravity flow for long-
term culture. Thus, the presented technology greatly improves the reliability and 
throughput of the assays. With orders of magnitude higher throughput, we successfully 
performed the single-cell-derived sphere assays of SUM159, MDA-MB-231, C6, and 
MCF-7 cells. In addition, we examined the difference between stem and progenitor cell 
potential of Notch+ and Notch- breast cancer cells. 
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CELL PAIRING RATIO CONTROLLED MICRO-ENVIRONMENT WITH 
VALVE-LESS ELECTROLYTIC ISOLATION  
This chapter covers the ratio controlled cell-cell interaction chip, which can precisely 
control the number of interacting cell types to accurately model cancer cell niches and 
provide spatio-temporal control of microenvironments for cell-cell interaction. To isolate 
chambers without using any valves or external pneumatic pumps, we introduced a novel 
actuation method by generating electrolytic bubbles to block the flow. 
4.1 Introduction 
The cancer cell niche is a complex microenvironment, consisting of cancer cells, 
endothelial cells (EC), macrophages and mesenchymal stem cells (MSC); and tumor-
stromal interaction is one of critical factors effecting the development of tumors [1-3]. It is 
believed that tumor cells can exploit nearby normal cells to enhance tumor growth, 
metastasis and drug resistance. Without establishing or accessing a proper micro-
environment, the cancer cells may die or stay in senescence forever [4-5]. Recent papers 
revealed the interaction feedback loops between breast cancer and mesenchymal stem cells 
[6]. For example, SUM159 (breast cancer) cells form a positive feedback interaction with 
mesenchymal stem cells via IL-6 and CXCL7 cytokines. As a result, the existence of 
mesenchymal stem cells in the cancer niche can accelerate tumor development. It has been 
also reported that immune cells play a critical role in cancer metastasis by triggering 
inflammatory response in the tumor micro-environment [7-8]. Tumor associated 
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macrophages (TAM) can enhance angiogenesis, and thus metastasis, by secreting a wide 
range of growth factors and cytokines. Endothelial cells also contribute to the invasion and 
metastasis of cancer by promoting cancer stem cell phenotypes and enhancing cancer 
metastasis [9-10]. Compared to the late stage tumor cells, these tumor associated cells are 
less drug resistant; thus killing these tumor associated normal cells can be used to deter the 
cancer development [11]. Inhibiting the interaction between tumor cells and tumor 
associated normal cells can be an alternative therapy. As a result understanding cancer-
niche interactions is of great importance for developing cancer therapeutics. 
 
Conventionally, cell interactions can be studied by co-culturing two cell types in the 
same petri dish [12]. However, dish-based co-culture methods are limited in several key 
aspects. Metastatic cancer cells are typically transported as a single CTC, and 
tumorigenesis from a single cell is quite different from co-culturing many cells [13]. As 
cancer metastases account for more than 90% of cancer-related mortality, modelling the 
tumorigenesis process in an appropriate microenvironment from a single cell is essential 
for metastasis study [3,14-15]. As the cell behaviour can be affected by neighbouring cells, 
the conventional dish culture cannot ideally model the tumorigenesis process [16]. Another 
limitation of conventional co-culture assays is its poor spatial control. In conventional 
interaction experiments, two cell populations are simply mixed in a dish, so the spatial 
distribution of two cell types can vary from one place to another. Some cells may be 
surrounded by a large number of different types of cells, while others may form aggregation 
of the same type of cells. Hence, the precise ratio controlled co-culture cannot be achieved 
by the conventional dish co-culture. Also, dish-based methods lack the ability of using 
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small samples (< 1000 cells), while CTCs and primary samples are more often available in 
a small sample. Finally, dish-based studies cannot track individual behaviors of 
heterogeneous cancer populations. They can only characterize the average behavior of 
entire cell population. This is an issue as some sub-populations in tumor have a different 
interaction pathway. For example, it is believed that only the aldehyde dehydrogenase 
positive (ALDH+) cells have strong interaction with MSC [6]. 
 
There are a number of previous works reporting on microfluidic platforms for cell-to-
cell interaction studies [17-28]. Most of them still require loading hundreds or thousands 
of cells in a device; thus, they suffer from the same issues as in the conventional dish-based 
co-culture [17-23]. Droplet based technology can provide a high-throughput combinatorial 
pairing of cells, but it lacks the capability of long-term cell culture, limiting its applications 
in practical co-culture assays [24] Recently, three microfluidic devices reported the cell 
pairing and cell-to-cell interaction at single-cell resolution [25-28]. However, they can only 
achieve the pairing of two different cells at 1:1 ratio due to geometric restrictions in the 
device structures. Actually, the cell ratios in tissue can matter in differentiation and it is 
important to screen assays for many different cell ratios to emulate in-vivo niches [29]. In 
this work, we present a reliable microsystem capable of performing cell interaction assays 
with a specific ratio between the two different cell types. By applying a hydrodynamic cell 
capture scheme in two different fluidic streams, we can precisely control the number of 
captured cells in each type. The captured cells interact through a bridge channel by 
diffusion of secreted cytokines. Although juxtacrine (contact-dependent) signalling also 
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plays a role in cell-cell interaction, we focus on the secretion based interaction, which has 
been proved to be important in the interaction between cancer cells and MSCs [6]. 
A major innovation of the proposed microfluidic platform is the electrolytic valving, 
which generates bubbles to isolate paired cells in a chamber. In previous cell isolation 
works, pneumatically actuated valves formed from thin PDMS membrane deformation 
were used [22, 26]. Although pneumatic actuation has been widely used for control in many 
microfluidic systems, such microfluidic devices need to be continually connected to the 
pump during the entire isolation process; otherwise, the pressure, and thus the cell isolation, 
will be released. This weakness limits the applications and usability of pneumatic valving, 
especially in mammalian cell culture, which may require specialized culture conditions and 
long term incubation. The electrolytic valving, on the other hand, can maintain the bubbles 
generated through electrolysis for isolation without continued external connection. In 
addition, the pneumatic valving is sensitive to channel geometry [30, 31]. Channel height 
and width need to be carefully designed and made rounded to guarantee completely sealing. 
As the electrolytic bubble can fill almost any shape to isolate the chambers, there are fewer 
design constraints in the use of electrolytic valving. Moreover, the electrolytic actuation 
circuit can be implemented compactly using ICs, while the programmable pneumatic 
control cannot be easily miniaturized. Thus, electrolytic actuation has a higher potential for 
miniaturization and extension to high-throughput as a standalone micro-system, especially 
for the applications that need long-term and continual isolation control. In this work, we 
developed an electrolytic bubble generation and removal scheme, which can be used to 
control cell-to-cell interaction times to within a precision of one minute. 
 
       
51 
 
For the proof of feasibility, we demonstrated the interaction between PC3 (prostate 
cancer) cells and C2C12 (myoblast) cells by secreted growth factors [32, 33]. We 
confirmed that the growth of C2C12 could be boosted by the secretion factors from PC3 
cells, and the proliferation rate of C2C12 be affected by the number of PC3 cells inside the 
same co-culture chamber. 
4.2 Microfluidic Device Operation 
 
Fig. 4-1. Proposed microfluidic chip for paired cell to cell interaction. (A) The cell culture 
chamber is surrounded by two bubble chambers both in the upstream and downstream. (B) 
Two different cells are loaded in the cell culture chambers respectively. (C) After cells 
attached on the substrate, the voltage is applied to the gold electrodes, and thus the bubble 
generated by electrolysis seals the cell culture chamber. As the cytokines secreted by cells 
can diffuse through the interaction bridge, the cells in two cell culture chamber can 
interaction with each other. (D) Since the PDMS is gas permeable, the bubble can be 
removed by applying negative pressure to the bubble removal channel. Thus, the time of 
cell isolation can be precisely controlled. 
 
The presented platform composes of cell culture chambers, interaction bridges for cell-
cell interaction, and bubble chambers with gold electrodes on the substrate (Fig. 4-1(A)). 
Two key features of the proposed system are the ability to control the number of cells and 
cell-to-cell interaction time. To address the first task, the cells were loaded from two 
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separate inlets. The number of loaded cells in a chamber can be determined by the number 
of capture sites in each chamber. To regulate the cell-cell interaction time, we used an 
electrolystically generated bubble for valve-less isolation of chambers. Each cell culture 
chamber is sandwiched by two bubble chambers in the upstream and downstream, 
respectively. When a sufficient potential for electrolysis is applied to the electrodes, a 
bubble can be generated, sealing the fluidic path. Then, the isolated cells in the chambers 
can interact through the interaction bridge by diffusion of secreted factors.  
 
Fig. 4-2. Enlarged microphotograph of a fabricated device. The light color region is the 
microfluidic layer which culture chambers, bubble chambers, gold electrodes and the 
bubble removal channels. The cell culture chamber is surrounded by two bubble chambers. 
The golden part shows the comb shape gold electrodes for electrolysis. 
 
Fig. 4-1 illustrates the operation of the presented microfluidic platform for paired cell-
to-cell interaction. In the cell loading phase (Fig. 4-1 (B)), cell A is loaded from the left 
inlet and captured in the left chamber, and cell B is loaded and captured in the right chamber. 
Since the pressure is balanced between the two fluidic streams, cell loading can be carried 
out without interference between the two laminar fluids. The number of captured cells (for 
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both type A and type B cells) can be determined by the number of cell capture sites in each 
chamber. After 4-6 hours, the captured cells will adhere to the substrate and remain viable 
and then proliferate within the microfluidic chambers.  
 
Fig. 4-3. Mechanism of Cell capture scheme: (A) The schematics of the cell valving capture 
(B) The simulated flow pattern before cell capture. The red arrows indicating flow 
direction and velocity suggest that the cells are likely to be guided to the capture site and 
get captured, and (C) After cell capture, the capture cell blocks the flow through capture 
gap, so the next cell will be guided to the serpentine path.   
 
In the electrolytic isolation phase (Fig. 4-1 (C)), voltage is applied to the gold electrodes, 
and bubbles are generated by electrolysis to seal the cell culture chambers. The cytokines 
secreted by the cells can be accumulated and diffused through the interaction bridge, so the 
cells captured in two separate sides can communicate with each other by protein signals. 
The interaction bridge is narrow (10 μm in width and height) and long (100 μm), so that it 
will prevent cells from migrating into the other side. The bubbles generated in the bubble 
chamber are stable over more than three hours. If a longer cell-to-cell interaction time is 
required, the electrolysis electrodes can be activated again to generate additional bubbles 
to maintain the isolation. The interaction can be stopped at any time by removing the bubble 
(Fig. 4-1 (D)). When negative pressure is applied to the bubble removal channel, the bubble 
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can diffuse out through the PDMS (50 μm thick) from the bubble chamber since PDMS is 
gas permeable. After the bubble is completely removed, media perfusion is resumed and 
the secreted proteins are washed away. Thus, the interaction stops. 
4.3 Cell Capture Mechanism 
 
Fig. 4-4. Ratio controlled cell pairing: (A) One of each PC3 (red fluorescent labelled) and 
C2C12 (green fluorescent labelled) cells, (B) Five PC3 cells and one C2C12 cell, and (C) 
Capture rate for various different numbers in capture sites: one, three, and five, 
respectively. 
 
In order to capture the specific number of cells in each culture chamber reliably and 
reproducibly, cellular valving mechanism has been adopted to deploy the cells 
hydrodynamically at each capture site (Fig. 4-3 (A)) [34-37]. To capture cells at each 
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designated capture site, two paths are created in the design: a central path and a serpentine 
path. The hydraulic resistance of each path is inversely proportional to its flow rate. As a 
result, the long serpentine structure has a higher hydrodynamic resistance than the central 
path. Thus, the cells, following the major flow stream, are likely to be guided to the central 
path (Fig. 4-3 (B)). Since the opening of the central path is slightly smaller (Height: 10 ȝm, 
Width: 10 ȝm) than the size of PC3 (human prostate cancer) cells and C2C12 (mouse 
fibroblast) cells, the cells are sterically captured and plugs the gap, blocking the flow 
through the central path. Thus, the next cells will be guided through the serpentine path 
and captured in the downstream capture sites (Fig. 4-3 (C)). After optimizing the serpentine 
length, a capture rate of ~90% has been achieved for C2C12, PC3, and Skov3 (ovarian 
cancer) cells (Table 4-1) 
Table 4-1. Optimized geometric parameters of capture sites for C2C12, PC3 and Skov3 
cells and the corresponding capture rates. 
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Fig. 4-5. Process of electrolytic bubble generation and removal. (A) Before electrolysis the 
bubble chamber was filled with cell culture media and the bubble removal channel was 
filled with air at atmospheric pressure. The blue line delineates microfluidic channels. (B) 
After 60 seconds of electrolysis, a bubble completely filled the bubble chamber and blocks 
the flow. The red dotted line is the outline of a bubble. (C) To remove the bubble, we applied 
negative pressure to the bubble removal channel. After 30 seconds, a bubble shrank in half. 
(D) After 60 seconds, the bubble was completely removed. (E) The volume of residual air 
in a bubble chamber as a function of time after applying negative pressure to the bubble 
removal channel. (F) The day 3 cell viability with and without the operation of electrolytic 
valve. No significant difference was observed, suggesting electrolysis has negligible effect 
on cell viability. (N = 4 devices) 
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By utilizing a high capture rate of single cells over 90% in each capture site, we can 
extend our design to capture multiple cells simply by adjusting the number of capture sites 
in each chamber. We can also deploy an arbitrary number (up to five) of two cell types in 
separate flow streams and study the effect of cell ratio in cell-to-cell interaction during co-
culture. Fig. 4-4 (A, B) shows the ratio-controlled cell capture: pairing one PC3 cell and 
one C2C12 cell (Fig. 4-4. (A)), and pairing five PC3 cells and one C2C12 (Fig. 4-4 (B)). 
We can vary the combination of pairing from 1:1 to up to 5:1 (or even higher). When the 
number of capture sites is equal to or smaller than five, more than 80% of the chambers are 
filled with the captured cells as shown in Fig. 4-4 (C). 
4.4 Electrolytic Isolation 
In continual media perfusion culture, secreted proteins will be washed away. Therefore, 
it is important for cell-to-cell interaction studies to control and sustain the isolation of cell 
culture chamber to accumulate the secreted proteins and cytokines inside the chamber. In 
this work, we achieve this by generating electrolytic air bubbles in the bubble chambers 
located between the adjacent cell culture chambers. Fig. 4-5 (A) shows a bubble chamber 
with gold electrodes and bubble removal channels. As the PDMS is gas permeable, small 
bubbles can easily diffuse out through the PDMS membrane within several minutes. To 
maintain stable channel isolation, we incorporate a large bubble chamber of 100 μm by 
100 μm and 40 μm in height (shown with a blue outline in Fig. 4-5) to facilitate the creation 
of a larger isolation bubble, which can sustain for more than 3 hours. If longer isolation is 
required, electrolysis can be performed again after 3 hours to sustain the bubble. Comb 
finger-shaped electrodes (20 μm in width for each comb finger and 20 μm in spacing 
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between fingers) can generate bubbles evenly inside the whole bubble chamber. Thus, the 
generated bubble can quickly and completely seal the whole chamber in a minute.  
The electric field as well as heat generated during electrolysis can be harmful to cells. We 
have implemented several techniques to minimize these effects. First, we tried to minimize 
electrolytic voltage. Since the minimum potential required for water electrolysis is around 
1.23 Volts, the applied voltage should be higher than this to overcome extra potential drops 
in the metal wires and media. However, the higher the voltage we use, the more heat we 
generate. We chose 3 V as an optimal voltage for on-chip electrolysis that can balance 
electrolytic efficiency and cell viability, based upon design parameters and preliminary 
experiments. With 3V as a peak operating voltage, we optimize the waveform. Compared 
to applying a DC voltage, a pulsed waveform can help dissipate the accumulated heat, and 
a large single bubble can be easily formed from multiple bubble generations from the comb 
finger-shaped electrodes. For these reasons, we chose to use a pulse wave (3 Volts, 0.1 Hz, 
1 μs pulse) for electrolytic bubble generation. The average power is less than 1 nW, and 
the resulting temperature increase in the cell culture chamber should be less than 0.01Ԩ 
(from simulation). After electrolysis for 60 seconds, a bubble can occupy the whole bubble 
chamber, and the culture chamber can be completely sealed and isolated (Fig. 4-5 (B)). In 
addition, we located the bubble chamber 500 μm away from the cell culture chambers to 
minimize the effect of any excessive heat generation and E-fields. 
As the electric field and heat generated by electrolysis can be harmful to the cells, we 
implemented several techniques to minimize the effect on cells. The E-field and heat can 
be minimized by using the proper voltage. Since the standard potential of the water 
electrolysis is around 1.23 Volts, the applied voltage should be higher than the threshold 
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to overcome resistance of the metal wire and the media. However, the higher the voltage 
we use, the more heat we generate. Considering the resistance of gold electrodes and the 
media, 3 Volts was determined as a suitable voltage for on-chip electrolysis that balanced 
the electrolytic and viability parameters. Once peak operating voltage is determined, the 
waveform is the next key parameter that must be optimized. Compared to continuous 
application of a DC voltage, a pulsed waveform can help dissipate the accumulated heat, 
and the rest between pulses allow time for the multiple bubbles generated by different 
electrodes to merge to form a larger single bubble. For these reasons, we decided to use a 
pulse wave (3 Volts, 0.1 Hz, 1 μs pulse) for the electrolytic bubble generation. The average 
power is less than 1 nW, and the resulting temperature change in the cell culture chamber 
is simulated to be lower than 0.01Ԩ. After electrolysis for around 60 seconds, a bubble 
occupied the whole bubble chamber, and the culture chamber was sealed completely 
(Figure 4-5 (B)). Also, to minimize the effect of E-field and excess heat, the bubble 
chamber is 500 μm away from the cells. 
4.5 Bubble Removal  
To precisely control the cell isolation time, the electrolytic bubble can be immediately 
removed at the end of interaction cycles. We achieve this by applying a negative pressure 
to the bubble removal channel. As the PDMS is gas permeable, the bubble can diffuse 
through the PDMS membrane [38-39]. We minimized the distance (50 μm) between the 
bubble chamber and the air removal channel to achieve rapid removal of bubbles in less 
than a minute. Fig. 4-5 (C, D) demonstrates the process of bubble removal. The red dotted 
line is the outline of the bubble, which occupied the whole bubble chamber after 
electrolysis. After applying negative pressure to the bubble removal channel for 30 seconds, 
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the bubble roughly shrank by half (Fig. 4-5 (C)); and after another 30 seconds, the bubble 
completely disappeared (Fig. 4-5 (D)). Using a negative pressure of around 7 psi, the 
bubble removal rate was measured as 0.4 nL per minute (Fig. 4-5 (E)). The bubble removal 
rate matches well with the predication from other reports [38-39]. We confirmed full 
functionality of the total 14 bubble chambers after ten cycles of bubble generation and 
removal, demonstrating the reliability and robustness of electrolytic sealing. 
4.6 Cell Interaction of PC3 and C2C12 cells 
In the fabricated platform, cell-cell interaction is induced from diffusion of secreting 
proteins through a narrow channel (10 μm by 40 μm, 100 μm long).  In order to verify 
whether this interaction bridge channel can provide adequate diffusion of secreted 
signaling proteins and cytokines for cell-to-cell communication, we simulated the diffusion 
of molecules similar to the secreted proteins (Fig. 4-6). The simulation results show that 
the two chambers reach almost steady state after 3 hours of isolation. The difference in 
protein concentrations between the two chambers connected by the interaction bridge 
channel is only 11% (Fig. 4-6 (E)), supporting that our platform can provide efficient 
diffusion flow for cell interaction in the given geometry of our design. In addition, the non-
isolated chamber was simulated (Fig. 4-7). As the secreted proteins are washed away by 
continual flow, the protein concentration of the receiving side is only 3.3% of that in the 
isolated chamber (Fig. 4-7 (E)). 
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Fig. 4-6. Simulations of diffusion for signaling proteins through a narrow bridge channel 
by COMSOL 4.3. We assume that single cell secretes 1-20 mole of proteins per second and 
its diffusion coefficient is 1-10 m2/s. We assume that the secreting cell is captured in the 
right chamber. We simulate the diffusion of signaling proteins from the right (secreting) 
chamber to the left (receiving) chamber for 3-hour isolation time. (A) Initial condition. 
Both chambers (left and right) have zero concentrations. (B) Concentration distribution 
after 1 hour isolation. (C) Concentration distribution after 2 hours isolation. (D) 
Concentration distribution after 3 hours isolation. (E) Concentration change of signaling 
proteins over time. Concentration of the receiving chamber (left) closely follows that of the 
secreting chamber (right). After 3 hour isolation, the concentration difference between two 
chamber is only 11%, confirming that the diffusion through a bridge channel is sufficient 
for adequate the cell-cell interaction. 
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Fig. 4-7. Simulations of diffusion for signaling proteins when washed through perfusion 
flow by COMSOL 4.3. We assume that single cell secretes 1-20 mole of proteins per second 
and its diffusion coefficient is 1-10 m2/s. As the chambers are not isolated, the secreted 
proteins are washed by perfusion flow of the media flowing from upstream to downstream. 
50 Pa was assumed as a pressure difference between the upstream and downstream. 
Initially, the concentration is assumed zero and the secreting cell is captured in the right 
chamber. (A) Initial concentration distribution. (B) Concentration distribution after 1 hour. 
(C) Concentration distribution after 2 hours. (D) Concentration distribution after 3 hours. 
(E) Concentration change of signaling proteins over time. As the secreted proteins are 
washed away by perfusion flow, the protein concentration in the receiving chamber (left) 
is only 3.3% of that of the isolated case after 3 hours, confirming that cell-cell interaction 
is negligible. 
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4.7 Cytokine Diffusion through Bridge Channels 
A novel microfluidic cell-to-cell interaction chip has been developed to control specific 
cell-pairing ratios for cell interaction assays. Electrolysis has been adapted to generate 
bubbles to block the media flow and isolate the culture chambers, so the captured cells can 
interact with each other by chemical secretions. Combining the fast electrolytic bubble 
generation and removal, the proposed platform can isolate paired cells for an arbitrary 
amount of time. The proposed electrolytic isolation scheme does not impose restrictions 
on the geometry of the capture design, so we can achieve a cell capture rate (for 1 to 5 cells) 
of more than 80% in all the fabricated chambers. The cell viability tests confirmed that the 
electrolysis and bubble removal operation will not affect the cell viability and proliferation 
rate. As a proof of the concept, we have demonstrated a cell interaction assay between 
C2C12 and PC3 cells utilizing different cell-pairing ratios on chip.  This work not only 
demonstrates the capability of performing ratio controlled cell-to-cell interaction assays, 
but also shows the compatibility of electrolysis in microenvironment control for cell culture. 
4.8 Cell-to-Cell Interaction Assays from Co-Culture of PC3 and C2C12 cells  
Before carrying out biological assays in the fabricated devices, we evaluated the effect 
of electrolysis on cell viability. Since the air generated from electrolysis has more than 
1,000 times the volume of the liquid (media), only a small fraction of the media (< 0.005%) 
in the chamber is consumed. Thus, the change in the media concentration is negligible. 
Also, the culture media is a buffered media; therefore, the pH of the solution is resistant to 
possible fluctuations that may be introduced by electrolysis.40 Three-day cell viability 
experiments of C2C12 cells were carried out to confirm that there was indeed no effect on 
cell conditions. After electrolytic sealing for three hours once a day for three days, 86 % of 
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the captured single cells were still viable in the culture chamber. The cell viability was 
comparable to 89% viability observed in the control without electrolysis (Fig. 4-5 (F)). Fig. 
4-8 (A) shows that the proliferation of C2C12 cells with electrolytic bubble sealing is 
similar to that of the control cells without electrolysis.  
As a proof of concept, we demonstrated the interaction between PC3 cancer cells and 
C2C12 myoblast cells. PC3 are known to secrete a number of growth factors to enhance 
the growth of tumors [32]. In the previous work, it has been demonstrated that co-culture 
of PC3 cells and C2C12 cells can enhance the proliferation of C2C12 cells, but whether 
the ratio of two cell types can affect the interaction is not clear [26,33]. Using the fabricated 
prototype platforms, we loaded both PC3 cells and C2C12 cells in the same device with 
different ratios on Day 0. For simplicity, we compared only the two different ratios: “1:1” 
and “5:1” in this experiment. After cell loading, the bubbles were generated to seal the 
culture chamber for three hours once a day for three days.  
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Fig. 4-8. Cell proliferation of C2C12 cells with and without PC3 cells: (A) Proliferation 
rates of C2C12 cells with and without bubble isolation. The result confirms that the 
electrolytic isolation has negligible effect on proliferation. (B) C2C12 and PC3 cell-
interaction assays with and without bubble isolation after 3 days. Co-culturing of one 
C2C12 cell and five PC3 cells significantly enhanced the proliferation of C2C12 cells when 
electrolytically isolating the culture chambers. Data points represent means ± standard 
deviations (N = 4 devices), * refers to P < 0.05. (C) With 3 hours of chamber isolation per 
day for three days, comparing the proliferation of C2C12 cells co-cultured with 1 PC3 and 
5 PC3 cells, respectively, the latter showed a significantly higher proliferation rate, 
confirming that cell ratios are critical for cell interaction studies. Data points represent 
means ± standard deviations (N = 4 devices), ** refers to P < 0.05. (D) Without chamber 
isolation, no significant difference was observed in proliferation rates. Data points 
represent means ± standard deviations (N = 4 devices).  
 
We verified the effect of chamber isolation on cell-to-cell interaction assays. We loaded 
one C2C12 cell and five PC3 cells in the devices. We cultured cells for three days. In one 
device, we did not apply any electrolytic isolation (control). In the other device, we 
generated bubbles to isolate the culture chambers for cell-to-cell interaction for three hours 
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per day. The culture chamber sealed by electrolysis (Fig. 4-9 (A)) has significantly more 
C2C12 cells than the unsealed one (Fig. 4-9 (B)). This result implies that the growth factor 
secreted by the PC3 cells can enhance the proliferation of C2C12 cells.  Fig. 4-8 (B) 
compares the number of C2C12 cells after three day culture between the control (non-
isolated, non-interaction) and the cell-interaction assay. 
 
Fig. 4-9. Cell-cell interaction between C2C12 and PC3 cells: (A) C2C12 cell chambers 
after 3 day co-culture with five PC3 cells with electrolytic bubble isolation and (B) without 
electrolytic bubble isolation. 
 
The effect of different cell pairing ratios was investigated and compared. As five PC3 
cells secrete more growth factors than single PC3 cell, it is expected that proliferation 
enhancement would be more significant where C2C12 cells are paired with five PC3 cells. 
Fig. 4-8 (C) supports this hypothesis. In order to confirm that these effects indeed come 
from cell interaction as a result of building up of secreted factors in the isolated chambers, 
we conducted the same assay without electrolytic isolation as a control. Fig. 4-8 (D) shows 
that the pairing ratio does not give any effect on proliferation behavior without isolation of 
culture chambers. These experiments confirmed that both chamber isolation and cell ratio 
control are critical parameters that make significant effects on cell-to-cell interaction assays. 
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These preliminary results successfully demonstrated the capability of our microfluidic 
prototype devices as a potential platform for high-throughput cell-to-cell interaction assays. 
4.9 Chapter Summary 
A novel microfluidic cell-to-cell interaction chip has been developed for precise control 
of cell-pairing ratios and cell-to-cell interaction time. Using hydrodynamic capture 
schemes in a dual streams in laminar flow, we achieved a high cell capture rate over 80% 
in pairing cell ratios from 1:1 to 1:5. We implemented a cell isolation scheme based on 
electrolytic bubble generation and removal without using any on-chip microvalves or 
external pneumatic pumps. As the bubbles can be generated and removed within a minute, 
the presented platform can precisely control the cell interaction time for the paired cells 
inside a chamber. We confirmed that cell viability and proliferation rates are not affected 
by electrolysis and bubble removal operations. As a proof of the concept, we have 
performed the cell interaction assays by co-culturing C2C12 and PC3 cells in different cell-
pairing ratios using the fabricated chip. Experimental results showed that proliferation rate 
was enhanced where C2C12 cells were co-cultured with higher pairing ratios of PC3 cells. 
This demonstrated the capability of our microfluidic prototype devices as a potential 
platform for high-throughput cell-to-cell interaction assays, and the compatibility of 
electrolysis for spatial temporal microenvironment control during cell culture. 
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PAIRED SINGLE CELL CO-CULTURE MICROENVIRONMENT ISOLATED 
BY TWO-PHASE FLOW WITH CONTINUOUS NUTRIENT RENEWAL 
This chapter introduces a single cell co-culture platform that implements actuation-free 
isolation using two-phase immiscible flows while providing continuous renewal of media 
through a semi-permeable membrane for long-term co-culture.  
5.1 Introduction 
The cancer cell niche is a complex microenvironment where cancer cells, endothelial 
cells (EC), macrophages, and mesenchymal stem cells (MSC) coexist [1], and tumor-
stromal cell interactions can determine the development of the tumor [2]. It is believed that 
tumor cells exploit nearby normal cells to enhance growth, metastasis, and drug 
resistance. Conventionally, cell interactions can be studied by co-culturing two different 
cell types in the same petri dish. However, this dish based co-culture model lacks several 
key aspects to comprehensively understand cancer development. First, metastatic cancer 
cells typically metastasize as single circulating tumor cells (CTC); therefore, single-cell-
derived tumorigenesis may be different from what is observed when co-culturing many 
cells [3, 4]. Second, conventional dish culture cannot provide an accurate model of 
tumorigenesis processes, as cell behavior will be affected by uncontrolled interaction with 
multiple neighboring cells [5]. In conventional interaction assays, two cell populations are 
simply mixed in a dish, so the spatial distribution of two cell types is not uniform, resulting 
in significant variation between locations. Some cells may be surrounded by many of the 
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other type of cells in one region, while others may aggregate with the same type of cells in 
another region. As such, it is difficult to achieve precise ratio controlled co-culture in the 
conventional culture platforms. Third, dish-based culture lacks the ability to use small 
samples (<1,000 cells). This is important because it is difficult to acquire large samples of 
CTCs or primary samples. Finally, for highly heterogeneous populations such as cancer, 
dish-based co-culture can only monitor the average behavior, rather than tracking 
individual cell behavior. This can be an issue because some sub-populations in tumors have 
different metastasis potential. Although microfluidic technology provides better control 
over co-culture microenvironment, many platforms still load hundreds or thousands of cells 
in the device, so they lack single cell resolution as conventional co-culture in petri dishes 
[6-14]. 
Although the single cell co-culture on-chip allows for isolating single cells in the 
chamber, there are still two critical issues to be resolved: 1) Due to the small amount of 
secreted proteins from single cell, continuous perfusion can easily wash away the secretion 
and thus impair cell-cell interaction; and 2) As the platform aims to study the heterogeneity 
of single cells, the chamber-chamber cross-talk, which can cause undesired interaction, 
should be eliminated. In the previous works reported on the single cell-cell interaction [15, 
16], the co-culture microenvironment of each cell group was not completely isolated. Thus, 
the cross-talk among different co-culture environments can inevitably distort the cell 
behaviors. Droplet based technology can naturally provide isolated co-culture 
microenvironment at single cell level; [17-19] however, droplet based cell culture is limited 
in the study of mammalian cells. First, most mammalian cells are adherent cells; therefore, 
suspension in a droplet can lead to anoikis, resulting in cell apoptosis [20]. Second, it is 
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difficult to continuously provide fresh media to each droplet, so the nutrition in the isolated 
droplet depletes over time. Previously, our group reported two different platforms, which 
are capable of controlling the isolation time of paired cells by pneumatic valve or 
electrolytic bubble generation and removal [21, 22]. In these platforms, the isolation time 
was optimized based on the accumulation of signaling proteins and nutrition depletion.  
Nevertheless, it is difficult to determine the optimal cell interaction time, especially for 
cancer cells, a highly heterogeneous population. Cells with low metabolism rates, which 
are likely to be quiescent and drug resistant, may need longer interaction times, while high 
metabolism rate cells, which contribute to rapid growth, may need a short interaction time. 
In order to fully characterize the sub-populations in the tumor, we should not miss any sub-
population behaviors. In addition, the difference in proliferation rates after culturing 
several days (some chambers with more cells and others with less cells) will make the 
situation even more complicated.  
In this work, we used a semi-permeable membrane for cell-cell interaction studies. The 
semi-permeable membrane under each micro-chamber can provide stable nutrient supply 
for cells, while retaining the secreted signaling proteins for interaction, without using any 
external control mechanisms for micro-chamber isolation. We incorporate immiscible oil 
isolation to achieve stable channel isolation in a simple and robust way. As a result, the 
device can operate without any external components such as micropumps or electrical 
control signals. For proof of feasibility, we demonstrated the interaction between UM-
SCC-1 (head and neck squamous cell carcinoma) cells and endothelial cells (EC). Secreted 
cytokines from ECs can boost the growth of UM-SCC-1 cells as compared to control 
experiments where UM-SCC-1 cells were cultured alone.  
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5.2 Microfluidic Device Operation and Device Fabrication 
 
Fig. 5-1. Schematics of the proposed cell-niche-on-chip. (A) Cells are loaded and captured 
in each chamber by paring with different types of cell. (B) Oil is introduced from left to 
right in the upper layer to isolate the culture chambers by immiscible oil. (C) Illustration 
of cross-sectional view of the device shows that secreted cytokines are accumulated inside 
the chamber for cell-cell interaction, while the nutrition can be steadily supplied through 
a semi-permeable membrane. 
 
The presented platform provides three functions: pairing of single cells for co-culture, 
oil isolation to avoid the cross-talk between chambers, and nutrient renewal through the 
semi-permeable membrane. To pair single cells, the hydrodynamic cell capture scheme is 
implemented. Using two capture sites per chamber, two cells can be captured in the same 
chamber as shown in Fig. 5-1 (A). After cell capture, the chambers are isolated by an 
immiscible oil phase. The oil flows left to right, so the cell chambers sandwiched 
by two parallel oil channels are isolated (Fig. 5-1 (B)). The nutrition can be supplied to the 
cells in the isolated chamber through the semi-permeable membrane (2k Daltons Cut-off 
molecular weight), while the secreted cytokines are accumulated inside the chamber 
because their molecule sizes (typically tens of kDa) are too large to escape (Fig. 5-1 (C)). 
In this manner, secreted cytokines are retained inside the chamber for cell-cell interaction, 
while the nutrition can be steadily supplied through a semi-permeable membrane.  
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Fig. 5-2. Fabrication process of the cell-cell interaction chip. 
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Fig. 5-3. The semi-permeable membrane used for nutrition exchange: (A) photo and (B) 
microphotograph. 
 
Three layers (cell culture layer, substrate with vertical connections, and the media 
exchange layer) were fabricated separately, and then all three layers were aligned and 
bonded (Fig. 5-2). For the cell culture layer, three masks were used to fabricate a SU8 
(Microchem) master mold: the first mask for a shallow (10 μm) interaction bridge, the 
second mask for microfluidic channels and cell culture chambers (40 μm), and the third 
mask for oil isolation channels (100 μm). The PDMS (PDMS, Sylgard 184, Dow Corning) 
layer was fabricated using the standard soft lithography processes. We used a 100 μm-thick 
fused silica wafer (Fused silica wafer, University wafer, MA) for substrate. In order to form 
vertical connections, a 50μm SU-8 layer was spin-coated and patterned and used as the 
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mask for DRIE. The fused silica was etched through by DRIE (Pegasus glass etcher), and 
the residual SU-8 was removed by PG Remover (Microchem). The media exchange 
channel was formed by HF etching of a glass substrate. The media exchange layer has 
many pillars (100 μm by 100 μm) to support the semi-permeable membrane (Dialysis 
Membrane 2K MWCO, Fisher Scientific) on top, and the images of semi-permeable 
membranes are shown in Fig. 5-3. The PDMS channel layer and the vertical connection 
layer were treated with oxygen plasma and then aligned and bonded together. Finally, the 
bonded PDMS-fused silica, semi-permeable membrane, and media exchange layer were 
all assembled and sealed utilizing UV cured Epoxy (OG147, Epoxy technology).  
5.3 Cell Capture Mechanism 
 In order to capture specific number of cells in each culture chamber, a cellular valving 
mechanism is used [23-25]. In this hydrodynamic capture scheme, two types of flow paths 
are created in the design: one is a central path and the other is a serpentine path, as shown 
in Fig. 5-4 (A). The hydraulic resistance of each path is inversely proportional to its flow 
rate. The long winding structure of the serpentine path is designed to increase the 
hydrodynamic resistance, so that the flow rate in this path is lower than that of the central 
path. Thus, the cells are likely to be guided to the central path and captured. Since the 
opening of the central path is slightly smaller (Height: 10 ȝm, Width: 10 ȝm) than the size 
of typical mammalian cells, the cells are sterically captured and plug the gap. Once the cell 
is captured, it blocks the flow in the central path and the remaining cells will flow through 
the serpentine path and be captured in the next chamber. With proper geometric design, a 
capture rate of ~90% can be achieved [25]. 
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Fig. 5-4. Simulations of flow velocity and pressure during cell capture in a chamber by 
COMSOL 4.3: (A) schematics of cell capture scheme showing two capture sites, a central 
path, and two serpentine paths, (B) The simulated flow pattern before cell capture. The red 
arrows indicating flow direction and velocity suggest that the cells are likely to be guided 
to the capture sites and get captured by either of capture sites. (C) After one capture site 
is taken, the next cell is guided and captured in the other capture site. (D) Once both 
capture sites are taken, the flow resistance through the central path becomes higher than 
that of serpentine paths, so the next coming cells will flow through the serpentine paths to 
the downstream. 
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Fig. 5-5. Multiple cells captured in a chamber: (A) Capturing of different combinations of 
UM-SCC-1 and endothelial cells (EC), and (B) the capture rate of different cell 
combinations in an array of chambers with two capture sites when loading the mixed cells 
of UM-SCC-1 and EC at a 1:1 ratio. 
 
 To pair cells for the interaction, we designed two capture sites in each chamber. As 
90% of individual capture sites capture exactly one cell, the number of captured cells in 
each chamber is determined by the number of capture sites in the design. As demonstrated 
by Fig. 5-4 (B), as the flow resistance of the central path is smaller, the first coming cell is 
likely to be captured by either capture site. The second coming cell will be captured by the 
other empty capture site (Fig. 5-4 (C)). Once both capture sites capture cells, the flow 
resistance through the central path becomes higher than that of serpentine paths, so the next 
       
77 
 
coming cells will flow through the serpentine paths to the downstream (Fig. 5-4 (D)). Using 
this mechanism, we can achieve a high cell-pairing rate in each chamber, and the same 
mechanism can work for higher number of cells per chamber. As the size of most 
mammalian cells is similar, there is no selectivity for cell type. Thus, the ratio of captured 
cells will be similar to the composition of cells in cell solution. For co-culture of two cell 
types, we loaded a 1:1 ratio of the mixed cells to maximize the probability of 1:1 cell-
pairing in the chamber. Fig. 5-5 (A) shows ten chambers capturing various combinations 
of cells after cell loading, and four chambers captured a pair of one UM-SCC-1 cell and 
one endothelial cell. Using two capture sites in each chamber, 25% of chambers capture 
exact a pair of two cell types, and other combinations can be generated simultaneously (Fig. 
5-5 (B)). The cell behavior of different combinations can be compared side by side in the 
same device, so the device-to-device variation can be obviated.  
5.4 Two-phase oil isolation  
The immiscibility between oil and water can be an ideal way to isolated microchambers 
(oil-water two-phase isolation). Previous works demonstrated isolation of water droplets 
in oil by optimizing channel geometry and hydrophobicity. Pico-liter water droplets can be 
generated in oil, [26-28] and each single droplet can be used as a nano-lab for cell analysis 
[29]. Mammalian cells were cultured in droplets, but cell anoikis and media depletion in 
the droplet limit these technologies only to short term culture (less than one day) [17-19]. 
On the contrary, the conventional media perfusion platforms can allow cell culture longer 
than two weeks without affecting cell viability [25]. These isolating microenvironments, 
however, need bulky external components such as pneumatic pumps or function generators 
for control. In this work, we combine the advantages of these two approaches by integrating 
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immiscible isolation for adherent cell culture and incorporating a semi-permeable 
membrane under each chamber to allow for continuous media perfusion [24, 26]. 
 
Fig. 5-6. Fabricated cell-cell interaction device. The cell culture chambers are separated 
and isolated by oil channels for cell-cell interaction. 
 
 In order to provide high cell viability for the long-term culture in our application, we 
optimized channel geometry to control the oil flow as shown in the Fig. 5-6. We designed 
a higher and wider channel (100 μm by 100 μm) for oil isolation paths and a narrower 
design (30 μm by 40 μm) for cell loading channels. In this channel configuration, the oil 
flow, driven by the negative pressure applied, can easily fill the wider channel and thus 
completely isolate the cell culture chambers, though oil has poorer affinity to the protein-
coated hydrophilic channels. It is difficult for oil to invade the cell culture chamber because 
the collagen coated PDMS is hydrophilic. As a result, the channel geometry can guarantee 
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good oil isolation while protecting cells inside the culture chamber. Fig. 5-7 shows the 
immiscible oil isolation process in the channel. A pair of cells were loaded in the chamber 
as shown in the Fig. 5-7 (A). When negative pressure was applied from the left, the oil 
filled the horizontal channels to isolate all the culture chambers. As we balanced the 
pressure difference between all horizontal channels, isolation process did not affect the 
cells captured in the chamber (Fig. 5-7 (B)). 
 
Fig. 5-7. Two-phase oil isolation: (A) before and (B) after oil introduction. The culture 
chamber forms an isolated microenvironment, and the oil isolation process does not affect 
the cells cultured in the chamber. 
5.5 Fabrication of vertical connections by DRIE process 
The presented platform has three critical functions: cell capture, oil isolation, and media 
exchange. To provide the same condition for all chambers on a chip, the symmetry of the 
channel routing is critical to maintain the pressure balance. However, symmetrical routing 
for both cell channels, oil channels, and media exchange channels on the same layer is 
unfeasible. To resolve this problem, we routed the media exchange channels in another 
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layer, and then connect both layers by vertical connections. As the substrate thickness is 
100 μm, it is impossible to make small vias (< 200 μm) by isotrpoic hydrogen fluoride (HF) 
wet etching. To make compact 3D integrated device, deep reactive-ion etching (DRIE) 
technology (Pagsus Glass etcher) was used instead. We used a fused silica wafer, which is 
pure silicon dioxide for two reasons: 1) The impurities in glass may interfere with the DRIE 
process, so it is difficult to achieve a high aspect-ratio deep etching on a glass wafer, and 
2) as the fused silica is pure silicon dioxide, it has the same ideal optical and 
biocompatibility characteristics as glass [30]. 
We fabricated different opening sizes, ranging from 25 μm to 300 μm, and all sizes 
could be etched through by the DRIE process as shown in Fig. 5-8. The measured etch rate 
was shown in Fig. 5-8 (C). The smaller the opening is, the slower the etch rate becomes. 
However, even for the vias of 25 μm in square, the etch rate was still comparable (~87%) 
to the larger vias. The process is quite reliable within the range between 25 μm to 300 μm. 
The size of via connection (25 μm x 25 μm) that we formed by using a silica wafer is by 
an order of magnitude smaller than the connections formed through a PDMS membrane 
(typically ~100 μm), allowing for more compact design. [31, 32] The fused silica substrate 
gives better mechanical robustness than PDMS thin membrane because it has a higher 
Young’s modulus. Utilizing the presented 3D vertical integration technique, we can 
eliminate the design constraints of conventional planar fabrication processes and increase 
the density of integrated chambers in a given area. 
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Fig. 5-8. Fabrication of vertical connections by DRIE: (A) the scanning electron 
microscope (SEM) of a 100 μm opening connection, (B) the SEM of a 25 μm opening 
connection, and (C) The etch rate of fused silica with different sizes of opening.  
5.6 Continuous media renewal and protein accumulation 
  The small pore size of a semi-permeable membrane allows retaining signaling 
proteins which typically have a large molecular-weight for cell-cell interaction, while 
passing the nutrient in the media which typically have a small molecular weight. The semi-
permeable membrane is sandwiched between the media exchange layer and the cell-culture 
chamber. Molecular weights of secreted proteins are typically larger than 10,000 Daltons; 
therefore, they will accumulate inside the culture chamber, inducing cell-cell interaction. 
Only the small molecules (e.g., glucose and amino acids) can pass the membrane, allowing 
continuous nutrient renewal from the media. Fig. 5-9 shows selective permeability based 
on molecular weight. The fluorescent dye in Phosphate-buffered saline (PBS, Gibco 10010) 
was loaded into the cell chamber, and the chamber was isolated by oil. Then, fresh PBS 
was supplied to the media exchange layer, so we can characterize the diffusion of 
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fluorescent dyes through the semi-permeable membrane as a function of molecular weight 
by measuring the fluorescent intensity change. We used two different fluorescent dyes in 
the experiment: a small molecule dye (Fluorescein 5(6)-isothiocyanate, F3651, Sigma-
Aldrich, Molecular weight of 389 Daltons) and a large molecule dye (Fluorescein 
isothiocyanate dextran, FD40S, Sigma-Aldrich, Molecular weight of 40,000 Daltons). Fig. 
5-9 (A-D) demonstrates that the small molecule dye can diffuse through the semi-
permeable membrane to the media exchange layer and then be washed away. The 
fluorescent intensity reduced to 27% from the initial intensity after 60 minutes. On the 
contrary, Fig. 5-9 (E-H) shows that the large molecule dye can be retained inside the 
chamber. After 60 minutes, the fluorescent intensity only reduced by 8%. Fig. 5-9 (I) plots 
the change of relative fluorescent intensity for two different dyes, respectively. It clearly 
shows the selective permeability for different molecule sizes, demonstrating the feasibility 
to continuous media renewal in the presented co-culture platform. 
5.7 Proliferation enhancement by cell-cell interaction  
As a proof of concept, we demonstrated cell interaction between UM-SCC-1 (head and 
neck squamous cell carcinoma) cells and endothelial cells (EC). Endothelial cells are 
known to secrete a number of growth factors that enhance the growth of tumors [33]. We 
compared co-culture of one UM-SCC-1 and one EC with single cell culture of one UM-
SCC-1. After cell loading, the chambers were isolated utilizing the immiscible oil for three 
days. In the chamber loaded with the EC, the secreted cytokines from the EC were 
accumulated over time and boosted the growth of the UM-SCC-1. Fig. 5-10 shows the 
proliferation results after three days. The isolated single tumor cell barely proliferated (Fig. 
5-10 (A)), while the UM-SCC-1 cell co-cultured with one EC proliferated to three cells 
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(Fig. 5-10 (B)). The proliferation rate of the co-cultured UM-SCC-1 cells was twice that of 
the isolated UM-SCC-1 cells (Fig. 5-10 (C)). Both isolated and co-cultured UM-SCC-1 
cells showed good cell viability, implying stable nutrition supply through the semi-
permeable membrane (Fig. 5-10 (D)) during the course of the experiments. By exchanging 
nutrition through the membrane, the presented platform can maintain the cell viability of 
75% up to 7 days for longer experiments. These preliminary results successfully 
demonstrated the capability of our device retaining the secreted factors for interaction 
while providing stable media perfusion through semi-permeable membrane to maintain 
good cell viability. 
5.8 Chapter Summary   
We have successfully implemented a cell-cell interaction platform that can be used to 
co-culture a pair of cells in one chamber. The platform attains a high cell pairing rate of 
25% and reliable chamber isolation by immiscible two-phase flows using oil. Although 
chambers are isolated, the nutrition can be supplied through a semi-permeable membrane, 
while the secreted signaling proteins can be retained inside the chamber for cell-cell 
interaction. The membrane selectivity based on molecular weights was verified utilizing 
fluorescent dyes. We achieved a compact integration of co-culture chamber arrays by 
stacking double layers through vertical via connections in the silica substrate. In the current 
chip, 56 chambers were implemented for proof of concept and we believe it can be easily 
extended to 1,000 chambers for high-throughput assays. The preliminary experiments have 
confirmed the increase in proliferation of cancer cells when co-cultured with endothelial 
cells, demonstrating the feasibility of the proposed microfluidic platform for studying 
tumor-stromal interaction by controlling microenvironments in cell niches.  
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Fig. 5-9. The selectivity of retaining fluorescent dyes based on molecular weights. (A-D) 
Small molecule dye (MW = 389 Da) was gradually diffused out through a semi-permeable 
membrane: (A) initial fluorescent intensity, (B) fluorescent intensity after 20 minutes, (C) 
after 40 minutes, and (D) after 60 minutes. (E-H) Large molecule dye (MW = 40,000 Da) 
was retained in the chamber: (E) initial fluorescent intensity, (F) fluorescent intensity after 
20 minutes, (G) after 40 minutes, and (H) after 60 minutes. (I) The plot of relative 
fluorescent intensity of fluorescent dyes in the chamber over time. The results clearly 
demonstrate that the small molecules (e.g., glucose, amino acids) can be exchanged, while 
the large molecules (e.g., signaling proteins) can be retained in the chamber for interaction 
(N = 5 chambers). 
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Fig. 5-10. Cell Interaction between UM-SCC-1 and EC for three days. (A) A single UM-
SCC-1 cell after 3-day culture in the chamber. No proliferation was observed. (B) A pair 
of one UM-SCC-1 and one EC co-cultured for 3 days. After three days, one UM-SCC-1 
cell became three cells. (C) The comparison between the proliferation rate of single UM-
SCC-1 cell and the co-cultured EC - UM-SCC-1 cells. The result shows that the EC can 
enhance the proliferation of UM-SCC-1 cell. Data points represent means ± standard 
deviations (N = 4 devices), P = 0.04. (D) Viability of UM-SCC-1 in the chamber after 3-
day culture shows that the cells were healthy in both cases. Data points represent means ± 
standard deviations (N = 4 devices), and no significant difference was observed. 
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HIGH CAPTURE EFFICIENCY SINGLE CELL DUAL ADHERENT-
SUSPENSION CO-CULTURE MICRO-ENVIROMENT 
This chapter covers a dual adherent-suspension co-culture device, which can provide 
both a suspension environment for cancer cells and an adherent environment for stromal 
cells in close proximity by selectively patterning polyHEMA in indented micro-wells. In 
addition, the platform specializes in high capture efficiency. Up to 75% of all cells used 
for small samples (50 cells) can be captured, granting the potential to study rare cell 
populations such as primary cells. 
6.1 Introduction 
Cellular heterogeneity is a hallmark of multicellular life and plays a critical role in 
many disease states [1-2], including cancer. A contributor of cancer heterogeneity in many 
tumors is cancer stem-like cells (CSCs). There is currently a wealth of data supporting the 
presence of CSCs, particularly in breast cancers [3-10]. In the CSC model, only a small 
subset of cells actually retains the ability to differentiate and initiate new tumors, as 
opposed to a traditional stochastic model of cancer where any cancer cell at low frequency 
may reform/recapitulate the entirety of a tumor [6, 9]. CSCs have been implicated in 
metastasis, radiation and chemotherapy resistance, and relapse after therapy, making them 
important clinical targets [5, 8, 11-12].  
It is believed that fibroblasts are a major micro-environmental regulator in cancer 
and are critical in tumorigenesis and metastasis [13-15]. Recently, it was demonstrated that 
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the co-transplant of cancer cells and fibroblast can boost the formation of cancer and that 
cancer associated fibroblast can skew the differentiation or de-differentiation of cancer 
stem cells [14-15]. As we expect different regulation of CSC stemness with fibroblast co-
culture, it is critical that we have a co-culture platform where we can maintain clonal 
spheres while providing signaling from adherent stromal cells. 
Although cancer-stromal interactions are critical in tumorigenesis, conventional dish 
based co-cultures lack the capability to study cell heterogeneity by tracking single cell 
behavior [13-15]. To understand a heterogeneous population such as cancer, ideal co-
culture platforms should be able to provide single cell resolution for characterizing 
individual cell behavior rather than the averaged behavior [16]. There are a number of 
previous works reporting on microfluidic platforms for cell-to-cell interaction studies [17-
29]. Most of them still require loading hundreds or thousands of cells in a device; thus, 
they still lack single cell resolution [17-23]. Droplet based technology can provide a high-
throughput combinatorial pairing of cells, but it lacks capabilities for long-term cell culture, 
limiting its applications in practical co-culture assays [24]. Recently, several microfluidic 
devices reported cell pairing and cell-to-cell interaction at single-cell resolution [25-29], 
but those works were limited to adherent cell co-culture. For applications in cancer biology, 
3D suspension culture is believed to maintain the stemness of CSCs, but suspension 
environments are too harsh for most adherent stromal cells (e.g. fibroblast cells, endothelial 
cells) [30, 31]. In this work, we developed the first co-culture platform combining both 
suspension and adhesion culture in close proximity inside the same chamber. Compared to 
previous single-cell platforms [32-35], the presented platform also specializes in high 
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capture efficiency, up to 75% of the loaded cells, even for small samples (50 cells). This 
enables the study of rare cell populations such as samples taken from primary cells. 
6.2 Design and Fabrication 
The presented co-culture platform is composed of an inner suspension culture chamber, 
an outer adherent culture chamber, and narrow interaction channels connecting them (Fig. 
6-1(A)). The whole device consists of 120 co-culture units (15 by 8) (Fig. 6-1(B)), and 
each unit is composed of the two culture chambers connected by 7 narrow (cross-section 3 
μm by 20 μm and 100 μm long) channels. To facilitate suspension and adherent culture on 
the same device, two layers of PDMS are used in fabrication. The bottom layer was 
patterned with indented microwells that were selectively coated with Poly-
hydroxyethylmethacrylate (polyHEMA, Sigma-Aldrich), which has been extensively used 
as an adhesion blocking coating material [34]. The top channels layer is patterned with 
microfluidic channels for flow control and chambers for co-culture. 
 
Fig. 6-1. microfluidic chip for adhesion suspension culture: (A) 3D schematics of a co-
culture chamnber having inner suspension culture chamber, outer adherent chamber and 
interacting channel connecting them, (B) photograph of a fabricated device having 120 
chambers within 8 mm by 10.5 mm core area, and (C) micrograph showing a fabricated 
co-culture chamber (scale bar: 100 μm). 
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These two PDMS layers (channel layer and substrate layer) were separately fabricated 
using standard soft lithography processes, and then aligned and bonded together, as shown 
in Fig. 6-2. For the channel layer, two masks were used to fabricate a SU8 (Microchem) 
master mold: the first mask for narrow interaction channels (3 μm height) and the second 
mask for main microfluidic channels and adherent cell culture chambers (40 μm height). 
One mask was used to fabricate the SU8 master mold for the substrate layer which has 
indented chambers (40um depth) for suspension cell culture. To make the chambers non-
adherent, polyHEMA was filled in the suspension culture chambers by a stamping process 
developed in our lab. The polyHEMA is in ethanol solution (60 mg/mL in 95% ethanol) 
and was coated on the substrate PDMS. A piece of blank PDMS was pressed on top to 
squeeze out the excess solution leaving the polyHEMA only in the indented micro-wells. 
To improve the coating quality, the indented PDMS substrate was plasma treated to 
increase the hydrophilicity. This will increase the likelihood that the polyHEMA ethanol 
solution will deposit only to the patterned PDMS substrate while stamping. Then, the 
substrate and the blank PDMS stamp were put on a hot plate at 110 Ԩ for 2 hours under 
pressure, in order to facilitate evaporation of ethanol through the PDMS layer. During the 
evaporation of ethanol, the polyHEMA layer will be deposited in the suspension cell 
culture chambers. To remove the undesired residual polyHEMA on the surface, 30 seconds 
of 800 Watt plasma polymer etching was performed using the YES polymer striper (the 
expected etching depth is 0.3 μm). This results in a clean PDMS surface with polyHEMA 
only left in the suspension culture chamber. The fabricated substrate is the then aligned and 
bonded to the other PDMS fluidic layer that contains the outer chambers and interaction 
channels. The fabricated device is shown in Fig. 6-1 (C). 
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Fig. 6-2. Fabrication process of the adhesion/suspension culture chip. 
6.3 Characterization of the fabricated surface  
First, we examined the surface profile of the fabricated substrates by SEM. Fig. 6-3(A, 
B) shows the surface profile before the filling of polyHEMA. We can clearly visualize the 
vertical side wall of the indented micro-well. After polyHEMA filling, the side wall of the 
indented micro-well becomes smooth. This indicates that polyHEMA was deposited on the 
substrate. If we remove the polyHEMA by plasma etching, we can observe the exposed 
PDMS on the bottom of the micro-well clearly in a SEM picture (Fig. 6-4). This indicator 
was used to determine the proper etching time. In addition, we measured the surface 
profiles using a laser interference microscope (LEXT, Olympus), as shown in Fig. 6-3(C, 
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D)). The deposited polyHEMA smoothens the cross-section of the micro-well. Based on 
the comparison of profiles, the polyHEMA coating depth at the center of the chamber is 
approximately 4 μm, which is sufficient to generate a non-adherent culture surface, based 
on our previous experiments. 
 
Fig. 6-3. Fabricated of non-adherent microwell: (A, B) SEM of microwell before and after 
filling polyHEMA and (C, D) surface profile of microwell before and after filling 
polyHEMA measured by LEXT. PolyHEMA was measured to be 4 μm thick in the center. 
(scale bar: 100 μm) 
 
To verify the effect of polyHEMA coating, T47D breast cancer cells were cultured 
on the selectively coated substrate, compared with an uncoated PDMS substrate and a 
standard tissue culture plastic dish. (Fig. 6-5). Due to the difference of stiffness between 
PDMS (500kPa) and the polystyrene (PS) dish (1GPa), the observed cell morphologies 
were slightly different, but still, the cells were clearly attached on the PS dish and the 
uncoated PDMS substrate. The uncoated PDMS was patterned in the same way as the 
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polyHEMA coated substrate (40um deep wells), and the cells are adherent both inside and 
outside of the wells (Fig. 6-5 (B)). Without the plasma etching process, a thin polyHEMA 
layer is formed on the top surface of the polyHEMA coated substrate. As such in Fig. 6-
5(C), we observed that cells remain rounded and aggregated on both the top surface and 
within the microwells, demonstrating that the T47D could not adhere. To attain dual 
suspension and adhesion culture on the same substrate, the residual polyHEMA was 
removed by the oxygen plasma etch. As the residual poylHEMA is much thinner (< 0.5 
μm) than the polyHEMA deposited in the wells (~ 4 μm), the polyHEMA coating inside 
micro-wells can be preserved, while removing all polyHEMA on the non-indented surface. 
Fig. 6-5(D) demonstrates the desired selective coating behavior. As the well is non-
adherent, cells formed aggregation in the well, while an adherent monolayer has grown on 
its surrounding area. In addition to T47D cell lines, multiple cell lines including C2C12 
(mouse myoblast), MDA-MB-231 (breast cancer), and HCC38 (breast cancer) cells were 
cultured on the substrate. The selectivity was observed in all these cell lines, indicating that 
the fabrication process is robust and reliable for suspension/adherent cell culture. 
 
Fig. 6-4. PolyHEMA over-etched indented chamber. The PDMS substrate exposes at the 
center of the chamber. 
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Fig. 6-5. T47D cells grow on the substrates of: (A) Petri dish (all adherent), (B) micro-
well without coating (all adherent), (C) surface coated with polyHEMA (all suspension) 
and (D) selectively polyHEMA coated substrate (suspension in the microwell but adherent 
elsewhere). (scale bar: 100 μm) 
6.4 Single cell isolation by Poisson's distribution  
To guarantee that cells cannot migrate between the inner and outer chambers, the 
interaction channels are designed to be 3μm in height, preventing migration while allowing 
paracrine based interactions. During operation, the stromal cells in the outer ring will be 
loaded first, and then allowed time to adhere to the substrate. The single cancer cells will 
be then loaded and captured in the micro-well for suspension culture and single cell derived 
sphere formation. Once the single cell is loaded into the indented well, it will settle to the 
bottom of the well as demonstrated by the fluidic simulation shown in Fig. 6-6. As a proof 
of concept, we demonstrated co-culture of T47D (breast cancer) and C2C12 (mouse 
fibroblast) cells to model tumor proliferation enhancement via fibroblast cell signaling. 
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The C2C12 cells, which require an adherent environment, were first loaded in the outer 
chamber (Fig. 6-7(B)). The cells were cultured with serum media (DMEM with 10% FBS), 
which contains attachment factors that encourage cell adhesion. After one day, cells were 
attached and grew to monolayer (Fig. 6-7(C)). As the interaction is much narrower than 
the size of cell, all coming single cancer cells were captured in the inner chambers (Fig. 6-
7(D)). 
  
Fig. 6-6. The flow simukations of the cell capture design: (a) the pressure distribution, (b) 
the flow velocity of the xy-plane, and (c) the flow velocity of the xz-plane. 
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Fig. 6-7. Cell loading process of the adhesion/suspension chip: (A) the schematics of a 
chamber of adhesion/suspension chip, (B) C2C12 cells loaded in the outer culture chamber 
on day 0, (C) C2C12 cells adhered and grew to monolayer on day 1, (D) single T47D cell 
(green fluorescent labelled) loaded in the inner chamber on day 1. 
 
Although conventionally hydrodynamic capture schemes can have higher capture 
rates (60-90%), they are not ideal for small samples such as primary cells or CTCs, due to 
lower cell capture efficiency (typically less than 10%). Additionally, it is difficult to 
implement a hydrodynamic capture scheme in our platform due to the high fluidic 
resistance of the narrow interaction channels. Compared to the hydrodynamic capture, that 
may lose cells through the serpentine (by-pass) paths, we can attain a high capture 
efficiency in the presented platform by collecting all incoming cells into chambers. 
Although the presented scheme cannot guarantee single cell in each chamber, the capture 
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distribution of cells in the chambers should follow Poisson's distribution. When the number 
of coming cells is much smaller than the number of the chamber, it is likely to have single 
cell per chamber. As a proof of the concept, we loaded 50 cells in a device having 120 
chambers, and 37 single cells were isolated in the chambers. The experimental results 
matched well with the Poisson distribution model (Fig. 6-8), showing that the capture 
scheme is suitable for the studies of small number (< 100) of cells.  
 
Fig. 6-8. The number of captured cell per chamber: (A) 50 cells loaded into a device with 
120 chambers and (N=4) (B) 100 cells loaded into a device with 120 chambers (N=4). The 
experiment results match well with the Poisson distribution. 
 
When having large number of cells, we can optimize the cell capture rate by controlling 
the number of loaded cells. As shown in the Fig. 6-9, if loading too less cells, we tend to 
have many empty chambers, while loading too many cells can cause a lot of multiple 
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captured chambers. Give the number of chamber per device, we can calculate the ideal 
number of loaded cells for the optimization of capture rate (~ 35 %). Although controlling 
the number of 50-100 cells can be difficult, two times higher or lower number of cells can 
only cause the degradation of performance by merely 20%, meaning that we can have 
robust loading performance.  
 
Fig. 6-9. The number of chamber capturing exact single cell per device (120-well device) 
with different number of loaded cells. 
6.5 Single cell derived sphere formation under the influence of stromal cells 
Though we designed the interaction channels to facilitate stromal interactions, it is 
important that we verify how secreted factors behave in the chamber. As shown in the 
simulations (Fig. 6-10) when media flows inward (from the outer ring to the inner 
suspension culture chamber), the media containing secretions from the fibroblasts can 
affect cancer cells located inside the inner chamber. Conversely, when media flows 
outward (from the inner suspension chamber to the outer ring culture chamber), the 
secretions from the cancer cell can affect the fibroblasts. When the flow is stopped, secreted 
factors from each population can diffuse throughout the chamber, allowing reciprocal 
interactions. As such, the platform has the potential to control the direction and type of 
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interaction. In our first trials, we alternated the flow direction, flowing inward for 12 hours 
and outward for 12 hours during each 24-hour period. 
 
Fig. 6-10. The simulations of cell secretion concentration in the chamber: (A) the 
discribution of cancer cell secretion, while the media flows from inner chamber to outer 
ring and (B) the discribution of fibroblast cells secretion, while the media flows from outer 
ring to inner chamber. The simulation was performed by assuming that single cell secretes 
1-20 mole of proteins per second, its diffusion coefficient is 1-10 m2/s, and single cancer and 
50 fibroblast cells in the beginning. 
 
After co-culturing the two populations for 14 days, we quantified the interaction 
efficacy by counting the number of single-cell-derived spheres present throughout the 120-
well array [35, 36]. Compared to single cancer cells cultured without stromal interaction 
(Fig. 6-11 (A)), the cancer cells co-cultured with fibroblasts (Fig. 6-11 (B)) have doubled 
the sphere formation rate, indicating that fibroblast cells can boost the stem/progenitor cell 
potential in the cancer population (Fig. 6-11 (C)). Co-cultured spheres were observed to be 
larger (Fig. 6-11 (D)), indicating a higher proliferation rate as well. In summary, we 
successfully demonstrated high capture efficiency in a close-proximity dual suspension and 
adherent co-culture environment, and also performed a co-culture assay for proof of 
concept. 
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Fig. 6-11. Differential cancer (T47D) sphere formation with and without co-culture with 
C2C12 cells: Representative cancer sphere on day 14 (A) without C2C12 or (B) co-
cultured. (C) Sphere formation rate with and without co-culture after 14-day culture. (N = 
4), ** P < 10-2. (d) Average sphere size with and without co-culture (N = 4), ** P < 10-
2. 
6.6 Chapter Summary 
We developed a single cell co-culture platform combining both suspension and 
adhesion culture in close proximity. Utilizing innovative substrate patterning, only the 
indented micro-chambers were non-adherent, while cells can adhere to other regions. The 
adhesion/suspension dual culture micro-environment has been proven reliable for 5 cell 
lines indicating its broad potential. The final device was fabricated by combining the 
substrate with a patterned channel layer, designed with a capture efficiency matching a 
Poisson distribution, specializing in small sample handling. For the 50 loaded cells, we can 
capture 37 single cells in individual microwells. As a proof of concept, we have performed 
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a cell interaction assay, co-culturing C2C12 and T47D cells in the fabricated chip. 
Experimental results showed that both sphere formation rate and the size of the single cell 
derived spheres were enhanced when T47D cells were co-cultured with C2C12 cells. This 
demonstrates the capability of our microfluidic prototype device to perform cell-to-cell 
interaction assays with a dual adhesion/suspension culture environment. 
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SINGLE CELL DETACHMENT AND RETRIEVAL IN THE MICROFLUIDICS 
USING PHOTO-ACOUSTIC EFFECT ON CNT/PDMS SUBSTRATE 
This chapter presents a novel cell detachment technique which provides good spatial 
resolution to selectively retrieve single cells from microfluidic chips. Pulsed laser beams 
were used to generate deformation on a CNT-PDMS composite film on which cells were 
adhered and cultured. Due to rapid (in milliseconds) deformation, cells can be detached in 
a non-thermal manner. This enables high cell viability and produces a negligible effect on 
the mRNA expression of single cell. 
7.1 Introduction 
Due to the genomic instability and epigenetic dysregulation of cancer cells [1-2], 
intratumor heterogeneity, imposes challenges in cancer therapy, as individual cells within 
a tumor can respond differently to the same drug. However, cell heterogeneity cannot be 
easily studied by conventional dish-based assays, which measure the averages from tens of 
thousands of cells at a time. Although FACS and MACS sorting instruments can separate 
tumor cells into several sub-populations based on cell surface markers, the markers may 
not correlate well with the cell behaviors that matter in the treatment [3]. Recent 
developments in microfluidics has enabled single-cell resolution assays that isolate and 
culture cells in an array of microchambers [4]. Cellular development can be monitored in 
the chamber, and in-situ sensors can characterize the metabolism or secretions of the single 
cells [5-7]. Nevertheless, when single cells proliferate in a chamber, it is difficult to 
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investigate the heterogeneity between two daughter cells from the same progenitor cell. As 
it is known that cancer stem cell (CSC) can undergo either self-renewal or differentiation, 
and this decision can determine the development of tumor, fully characterizing two sister 
cells can facilitate the fundamental understanding of the regulating pathways for cell 
renewal and differentiation in cancer development [8-9]. Since the off-chip analysis can 
provide higher multiplexing capability up to 96 mRNA (Fluidigm, C1, Biomark) and 32 
proteins (Fluidigm, CyTOF) for single cell analysis, the capability to retrieve a target single 
cell for off-chip analysis is critical.  
Conventional cell detachment schemes, such as trypsinization or PNIPAAm-based 
detachment [10], do not provide good spatial resolution; cells are detached from the entire 
substrate. The PALM CombiSystem developed by Zeiss can detach cells adhered on a 
laser-absorbing film. However, this system can only operate on an open substrate, so it is 
difficult to integrate it with microfluidics, which are ideal platforms for single cell 
manipulation and analysis. The methods using capillary vacuum or localized trypsin 
exposure can provide simple alternative methods for selective cell retrieval, but they are 
still limited to open substrates [11-12].  Cell release through photo degradation of a film 
substrate provides better spatial resolution and can be integrated with microfluidic devices, 
but this process generates acid and leads to toxicity that may affect cell behavior and 
expression. [13]. In 2012, an IR-triggered single cell detachment method using CNT 
substrates was reported [14]. However, cell viability was poor under direct laser irradiation 
because of heat-induced cell necrosis. Recently, we demonstrated cell detachment using 
ultrasound-induced cavitation [15], but unfortunately this approach only works on open 
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substrate and is not compatible with microfluidic arrangement due to acoustic attenuation 
in PDMS.  
Here, we present a new cell detachment technique which provides good spatial 
resolution to selectively retrieve single cells from microfluidic chips. Pulsed laser beams 
were used to generate deformation on a CNT-PDMS composite film on which cells are 
adhered and cultured. Due to rapid (in microseconds) deformation, cells can be detached 
in a non-thermal manner. This enables high cell viability and produces a negligible effect 
on the mRNA expression of single cell. 
7.2 Cell Detachment Mechanism and Fabrication of Microfluidic Platform  
We developed this novel cell detachment technology based on photo-acoustic 
mechanism. The cell detachment setup is illustrated in the Fig. 7-1. To convert the optical 
power from the laser to a mechanical force for cell detachment, we developed a two-layer 
composite substrate (shown in Fig. 7-2 (A)), which composes of a light absorbing material 
and a polymer layer. The light absorbing layer will transform the optical energy to heat, 
and the generated heat leads to the thermal expansion of polymer. The rapid (<1μs) 
deformation of the polymer layer can lead to high enough shear stresses to detach the cells 
on the surface.  Due to the high optical absorption of CNTs, they were first investigated as 
a light absorbing layer and deposited via CVD (Chemical Vapor Deposition). Later testing 
showed that sputtered Au/Pd alloy (20nm) can be used as the alternative light absorbing 
material, which has better uniformity and higher potential for scalable fabrication. PDMS, 
a commonly used microfluidic material, was selected as the polymer layer for three merits: 
(1) the high thermal expansion coefficient of PDMS helps transformation of the heat to a 
mechanical force [15], (2) the low thermal conductance can isolate the cells above from 
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the heat of the CNT surface, preserving cell viability, and (3) PDMS has good bio-
compatibility. The SEM picture of the CNT film (~ 6 Pm) grown on the substrate is shown 
in the Fig. 7-3. (A). To uniformly coat thin PDMS on CNT substrate, we diluted PDMS in 
Hexane with a 1:1 ratio. A 3Pm PDMS layer can be achieved using a 6,000 rpm spin 
coating speed (Fig. 7-3. (B)). The relation between PDMS thickness and the dilution ratio 
and spinning rate is characterized in Fig. 7-4. 
 
Fig. 7-1. Schematic diagram of single cell detachment setup. The target cell was cultured 
in the microfluidic chamber and observed under microscope. Once being selected, the 
pulsed laser can be used to detach the target cell. 
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Fig. 7-2. Schematic diagram of a single cell assay platform: (A) cross- sectional view and 
(B) 3D micro-chamber schematics with a captured cell.   
 
Fig. 7-3. SEM images of the substrates: (A) the CVD-grown CNT forest on quartz substrate 
(B) the embedded CNTs in the PDMS layer after spin coating of PDMS. 
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Fig. 7-4. The correlation between the PDMS thickness and the spinning rate and the 
Hexane dilution ratio: (A) PDMS thickness versus the spinning rate, when diluted 1:1 to 
Hexane, and (B) PDMS thickness versus dilution ratio, when fixing to 6000rpm. 
7.3 Selective Cell Detachment and Retrieval at Single Cell Resolution 
Using the hydrodynamic capture scheme, reported in chapter 3, we can capture single 
cells in each chamber of a microfluidic culture array with high efficiency (around ~ 80-90% 
[4]). The captured cells can grow in the microfluidic chamber for more than 14 days, so 
cell assays as diverse as drug screens, cell-to-cell interaction, cell migration, sphere 
formation, and cell differentiation can be performed in our platform. During such assays, 
it can be beneficial to retrieve cells of interest for further downstream analysis. A focused 
short-pulse of laser (3-5 ns) can be applied for cell detachment at single cell resolution. 
The laser energy (~0.1mJ per pulse) is absorbed by the CNT layer grown on the substrate 
(Fig. 7-3), transferring the energy to heat. The PDMS expands and deforms, inducing a 
high shear force to detach the cell. The low thermal conductivity of the PDMS layer 
insulates the cell culture area, so the generated heat does not affect cell viability. Fig. 7-5 
illustrates the detachment process of a single skov3 (ovarian cancer) cell. In the beginning 
(Fig. 7-5 (A)), the cell was captured in the chamber and allowed to attached to the substrate 
over a few hours. When the laser is used on the substrate near the cell, a shear force is 
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generated and the cell detached (Fig. 7-5 (B)). Driven by reversing the gravity flow, the 
cell travels upward to be retrieved in the outlet (Fig. 7-5 (C)). Fig. 7-6 demonstrates the 
precise spatial resolution of the presented detachment scheme. After focusing the 
irradiation to just one side of the cell, we can partially detach the cell, leaving one side 
anchored and the other free. 
 
Fig. 7-5. Process of single cell detachment: (A) before detachment, (B) after detachment, 
(C) when the detached cell flowing away. 
 
 
Fig. 7-6. Partial cell detachment: (A) before detachment, (B) after detachment, (C) a 
partially-detached cell anchored on one side and detached on the other. 
 
To facilitate further analysis (e.g. mRNA RTq-PCR) on the target cell, we designed 
a novel cell retrieval scheme that can achieve high yield retrieval and avoid undesired 
contamination from residual cells left in the inlet. In the cell loading phase, media flows 
from inlet to outlet (in Fig. 7-7, flowing from top to bottom), so the cells can be captured 
at the capture sites (Fig. 7-7 (A)). In the detachment phase, we first detach the cells from 
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the lower chambers (the even rows in the array) by applying pressure from the right (Fig. 
7-7 (B)). The detached cells in the lower chambers will be guided upward and retrieved in 
the left outlet. Then, we can detach the upper chambers (the odd rows in the array) by 
applying the pressure from the left (Fig. 7-7 (C)). The detached cells in the upper chambers 
will be guided upward and retrieved in the right outlet. Using the alternating parallel 
channels in an array, we can retrieve all the cells from left and right outlets, so the residual 
cells in the inlet during cell loading will not contaminate the sample.  
 
Fig. 7-7. Cell retrieval process by flow control: (A) Cell loading phase - The media flows 
downward in all chambers and cells are hydro-dynamically captured in each chamber, (B) 
Cell harvesting to the left.  After cell detachment, we harvest the cells in the lower chambers 
(the even rows) first by applying pressure from right to left. The detached cells in the lower 
chambers will be guided upward and then collected in the left outlet (C) Cell harvesting to 
the right - We retrieve the cells in the upper chamber (the odd rows) by applying pressure 
from left to right. The detached cells in the upper chambers will be guided upward and 
then collected in the right outlet. Using the alternating parallel channels in an array, we 
can retrieve cells from all the chambers. 
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Fig. 7-8. Selective retrieval of asymmetrically divided cells. (A) single Notch+ T47D cells 
was captured in a chamber. (B) After 3 days, the Notch+ cell asymmetrically divided to 
one Notch+ (green) and Notch- (non-green) cell. (C) The Notch+ cell was selectively 
detached and retrieved first. (D) Notch- cell was successfully retrieved. 
 
As a proof of concept, we demonstrated the selective retrieval of asymmetrically 
divided Notch+ T47D (breast cancer) cells. The Notch pathway is a signaling pathway that 
regulates cell self-renewal and differentiation, and high Notch expression is related to stem-
like properties and higher tumor initiating potential [16-17]. To monitor Notch pathway 
activation, we transduced T47D cells with a lentiviral (pGreenFire1) Notch reporter 
containing multiple Notch response elements upstream from a minimal CMV promoter 
regulating destabilized GFP. Due to asymmetric division, some Notch+ cells generate 
Notch- daughter cells, and this regulation is essential in the tumor development. Notch+ 
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cells were loaded in the chamber on day 0 (Fig. 7-8 (A)), and one was selected that 
asymmetrically divided to one Notch+ (green) and one Notch- (non-green) cell after 3 days 
(Fig. 7-8 (B)). First, we retrieved the Notch+ cell, and, due to the high spatial resolution, 
the Notch- cell stayed at its original place (Fig. 7-8 (C)). Then, the Notch- cell was retrieved 
(Fig. 7-8 (D)), so two daughter cells could be analyzed and compared. 
7.4 Viability of Detached Cells 
Fig. 7-9 shows the cell’s viability after recovery from laser induced cell detachment. In 
this case, a single cell was detached and then retrieved in a 96-well plate (Fig. 7-9 (A - C)). 
4 days after the detachment, it proliferated to around 30 cells. Using LIVE/DEAD staining 
(Life Technologies, USA), we found that all cells were viable. In Fig. 7-10, we compared 
the cell viability in our method with that of the conventional trypsinization-based method. 
Remarkably, cells that underwent the laser detachment scheme show slightly better cell 
viability than those that underwent the conventional trypsinization process, indicating that 
the presented method is suitable for the applications which need further culturing of the 
samples after retrieval. In addition to the viability test, we visualized the cells after detached 
by the laser or trypsinization process under SEM (Fig. 7-11). Trypsinization digest all the 
membrane proteins (giving the cells a smooth surface (Fig. 7-11 (B, D)), while the laser 
detachment preserves such surface proteins (leaving the cells rough under the SEM (Fig. 
7-11 (A, C)). The preservation of these membrane proteins enhances the cell survival, 
helping to explain the observed higher cell viability. In addition as the surface markers will 
be preserved in the laser detachment process, marker staining will not be affected and can 
be performed soon after retrieval. 
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Fig. 7-9. The recovery of a MDA-MB-231 cell after laser detachment: (A) before 
detachment, (B) after detachment, (C) retrieved in the 96-well plate, and (D) 4 days 
recovery showing healthy proliferation. 
 
Fig. 7-10. Cell viability of MDA-MD-231 cells 4 days after the detachment by laser (the 
presented scheme) and by trypsin (the conventional scheme), respectively. Laser 
detachment shows better viability. 
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Fig. 7-11. The scanning electron microscope (SEM) of laser detached and trypsinized 
cell: (A) a laser detached MDA-MB-231 cell, (B) a trypsinized MDA-MB-231 cell, (C) 
Enlarged view of a laser detached MDA-MB-231 cell, and (D) Enlarged view of a 
trypsinized MDA-MB-231 cell. 
7.5 Single Cell Gene Expression 
Although we demonstrated good cell viability and surface protein preservation, laser 
detachment may induce a cellular stress response that alters gene expression [18]. We 
characterized the mRNA expression of 96 genes comparing 20 laser detached and 20 
trypsinized cells. Fig. 7-12 is the principle component analysis (PCA) plot showing the 
characteristics of each single cell as a dot. The cells detached by different methods are 
marked by different colors (trypsizined cells are green, while laser detached ones are red). 
In the plot, the two populations mix together, meaning that no distinguishing feature can 
be found that separates the two populations. The Hierarchical Clustering (HC) plot (Fig. 7-
13) groups cells with similar expression together like a family tree. Again, the two 
populations are mixed in the center, showing that the heterogeneity within group is larger 
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than the difference between two detachment methods. Fig. 7-14 is the violin plot of the 
trypsinized cells and the laser detached cells. The cells detached by both methods maintain 
typical T47D cell expression such as high EPCAM and low Vimentin, and no significant 
difference was found.  
 
Fig. 7-12. The Principal component analysis (PCA) plot of trypsinized (green) cells and 
the laser detached (red) cells. The cells in both populations mix in the plot, meaning no 
significant difference in gene expression by two detachment methods. 
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Fig. 7-13. The Hierarchical Clustering (HC) plot of trypsinized (green) cells and the laser 
detached (red) cells. The cells detached by both methods mix in the plot, meaning no 
significant difference was observed by two detachment methods. 
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Fig. 7-14. The violin plot of trypsinized (green) cells and the laser detached (red) cells. 96 
genes expression of each single cell was analyzed. The y-axis is the relative expression, 
and the x-axis is the distribution of the population. The cells detached by both methods 
maintain typical T47D cell expression, and no significance was found. 
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7.6 Chapter Summary  
Combining our single cell capture scheme and cell detachment and retrieval 
capabilities, we can monitor the development of a colony formed by single cells and then 
retrieve specific cells with interesting morphologies within a colony for further analysis. 
This capability open new possibilities in the study of cancer cell heterogeneity during 
tumor development. As a proof of concept, we harvested two asymmetrically divided 
daughter cells from the same progenitor cell. The presented method can maintain good cell 
viability and preserve the membrane proteins after detachment. In addition, the gene 
expression will not be altered in this process as compared to trypsinization. These 
preliminary data prove that the presented cell retrieval method is suitable for the 
applications needing further off chip cell culture or mRNA expression analysis. Such 
techniques will be invaluable in studies of highly heterogeneous cancer cell populations.   
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CONCLUSION AND FUTURE WORKS 
 
This thesis presented several microfluidic platforms for the study of cancer metastasis 
on chip and a selective single cell retrieval tool for the genotypic and phenotypic analysis 
of cell heterogeneity. This chapter summarizes the works that has already been completed 
and discusses the possible improvements and applications in the future. 
8.1 Conclusion 
The accomplishments of this thesis focus on single cell microfluidic platforms for 
emulating three main stages of cancer metastasis and a selective single cell retrieval tool 
based on a photo-acoustic release mechanism. First, a single cell migration chip, which 
positions single cells at the long capillary channels and provides a stable chemical gradient 
to induce cell migration was developed. The chip is designed to study cancer metastasis by 
measuring the motility and chemo-attraction of cells at a single cell resolution. We can 
screen for drugs (or reagents) that inhibit metastasis, and identify biological signals that 
attract the cells. In addition to the migration assays, the platform also provides a method 
for motility based cell behavioral sorting. Highly motile and non-motile cells can be 
selectively retrieved from either side of the capillary channels after a migration assay. The 
retrieval process was show to have no effect on cell viability and was shown to enable 
downstream analysis. The preliminary results show that the demonstrated characteristics 
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of sorted cells are maintained after retrieval and further culture, allowing for further 
downstream studies in the difference between highly motile and non-motile cells.  
Second, I designed a single cell suspension culture chip, which can capture a total of 
1,024 cells in a microwell array at single cell resolution and provide a suspension cell 
culture environment using a polyHEMA surface coating to prevent cell adhesion. Using 
the platform, the cells are individually separated into each chamber; this will not only 
prevent uncontrolled cell aggregation, but also, enable tracking of individual cell behavior 
within heterogeneous populations. Although polyHEMA has been used for suspension cell 
culture in petri dishes, the conventional polyHEMA coating technique provides poor 
uniformity due to using an uncontrolled evaporation process. Spin-coating is a well-defined 
process and is widely used in microfabrication. Here, it was used as a polyHEMA coating 
technique to provide greater control of spreading and evaporation. Even though pinholes 
and trapped bubbles are generated during spin-coating, these defects can be removed by 
double spin-coating and including a high temperature reflow of the deposited polyHEMA 
as the final step. With the optimized coating protocol, the surface roughness can be reduced 
to 0.2 μm, which is only 6% of the roughness introduced in the conventional coating 
process. This greater uniformity facilitates successful integration with our microfluidics.  
Integrating the single cell device with the polyHEMA substrate, we demonstrated different 
anoikic behaviors between stem-like and non-stem-like SKOV3 ovarian cancer cells. In 
addition, the integrated platform allowed for single-cell-derived sphere formation assays. 
The platform provides a continuous perfusion of media from gravity flow to improve the 
reliability and throughput for long-term culture. We successfully performed single-cell-
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derived sphere assays of patient derived xenograft (PDX) cells and breast cancer cell lines 
including SUM159, MDA-MB-231, and MCF-7 and T47D cells.  
To facilitate investigation of cell-cell interactions at a single cell level, I developed a 
ratio controlled cell-cell interaction chip, specializing in controlling the number of 
interacting cells and microenvironment using a novel actuation method. Electrolytic 
bubbles are generated to block flow and isolate the microwells without using any valves or 
external pneumatic pumps. In addition, another platform was designed in which actuation-
free isolation was implemented using two-phase immiscible flows while providing 
continuous renewal of media through a semi-permeable membrane for long-term co-
culture. Furthermore, I implemented a dual adherent-suspension co-culture device, which 
can provide both a suspension environment for cancer cells and adherent culture for stromal 
cells in close proximity by selectively patterning polyHEMA in indented micro-wells. 
Using this platform, up to 70% of the loaded cell can be captured for small sample sizes 
(50 cells), enabling the analysis of rare cell populations such as primary cells or CTC. 
In addition to the microfluidic platforms, I developed a selective single cell retrieval 
tool, which can retrieve interesting single cells from the microfluidics for further analysis. 
Cells are cultured on a CNT-PDMS composite film, which can be deformed using pulsed 
laser exposure. Due to the rapid (in milliseconds) deformation, cells can be detached in a 
non-thermal manner and then retrieved by precise flow control. Combining our single cell 
capture scheme, cell detachment, and retrieval capabilities, we can monitor the 
development of a colony formed by single cells and then retrieve specific cells with 
interesting morphologies or other characteristics within a colony for further analysis. These 
capabilities can enable new studies of cancer cell heterogeneity that were not previously 
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possible with conventional FACS sorting techniques. We demonstrated that the presented 
method has a negligible effect on cell viability and preserves the membrane proteins after 
detachment. In addition, gene expression of laser detached cells is similar to the cells 
detached by trypsinization, indicating little expression alteration caused by laser 
detachment. These preliminary data prove that the presented cell retrieval method is 
suitable for applications where further off chip cell culture or mRNA expression analysis 
is desirable. 
8.2 Future Works 
8.2.1 Study the self-renewal and differentiation of cancer stem cell  
 To expand on the use of our single cell retrieval tool, we would like to study the 
regulation of the differentiation and self-renewal of cancer stem-like cells (CSCs), which 
are known to be tumorigenic. The regulation of differentiation and self-renewal is an 
interesting fundamental science question, and skewing CSC towards differentiation could 
be a promising therapeutic opportunity. Conventional FACS sorting machines can only 
separate CSC and non-CSC, without visualizing the cell division process, and thus, FACS 
lacks the capability to distinguish the CSC that gives rise to non-CSC (differentiation) and 
the CSC that gives rise to only CSC (self-renewal). Combining the microfluidic single cell 
capture scheme and the cell retrieval capability, we can decipher CSC differentiation or 
self-renewal regulation pathways. The single CSC can be loaded and monitored in the 
micro-chamber, and after proliferation, the two daughter cells (of either symmetric or 
asymmetric division) can be retrieved for off-chip analysis. Then, the difference between 
the differentiating CSC and self-renewing CSC can be compared via genomic analysis.  
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8.2.2 Use primary cancer cells in the microfluidics 
Although I have successfully developed microfluidics tools for the on-chip emulation 
of cancer metastasis, the use of primary cells from patient has not yet been fully explored. 
We have preliminary success in growing spheres from single patient derived xenograft 
(PDX) cells in the single cell suspension culture chip, and similar approaches can be 
applied to the newly developed dual adhesion-suspension cell-cell interaction platform, 
targeting the cell-cell interactions between primary cancer cells and fibroblast cells. It is 
believed that cancer cells can influence the surrounding fibroblast cells, creating tumor 
associated fibroblast that provide a favorable environments for cancer development, drug 
resistance, and metastasis. After co-culture, we can exam the sphere formation results and 
then study the molecular signature of single cells, as we did in the Chapter 3, to understand 
the effect of the fibroblasts on the cancer cells. In addition, we can also retrieve the 
fibroblast cells to compare their expression to bulk primary fibroblasts. Although more 
challenging, the use of primary samples can greatly increase the impact of in-vitro 
microfluidic work and better recapitulate in-vivo biology on-chip. 
8.2.3 Small sample preparation by microfluidics 
Although we can manipulate single cells in microfluidics, the sample preparation and 
interfacing of these microfluidic approaches and conventional bulk analysis machines is 
challenging. As the bulk tools typically use large volumes (mL), while microfluidic tools 
prefer to handle small volumes (μL – nL), the dead volume lost during interfacing and 
centrifugation can be significant. As an example, when using circulating tumor cells 
(CTCs), which have great potential for diagnostics and personalized medicine, it is typical 
to have less than 10 cells per mL of patient blood. Using conventional dish based 
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approaches such as western blot and qRT-PCR, tens of cell cannot be used to generate 
meaningful data in the assays, because the large volume dilutes the concentration of 
proteins and mRNA of the cells. Even though microfluidics can analyze smaller number or 
even single cells, the volume (mL) of the CTC samples is too large to be loaded in most 
microfluidic platforms. For example, the C1™ Single-Cell Auto Prep System (Fluidigm 
can only load 3μL into its microfluidic chip. Given a cell concentration of 10 cells per mL, 
almost no cell can be loaded for analysis of CTC. Centrifuge can help increasing the cell 
density, but the majority of cells will be lost in centrifuging process for three reasons: (1) 
reducing the volume from mL to μL is fundamentally challenging, (2) when the number of 
cells is really small (10-50 cells), cells cannot aggregate well into a pellet, and (3) fragile 
primary samples cannot endure high centrifuging force (typically should be lower than 100 
– 300 relative centrifugal force (RCF)). Thus, we are working on implementing a 
microfluidic cell condenser interface stage, which can enrich low density cell solutions to 
minimize the interface loss.  Such advances in small sample preparation are promising both 
for research and commercialization applications. 
8.2.4 Cell sorter based on behavior  
Cell heterogeneity is known to be a critical issue in cancer research, but conventionally, 
cell heterogeneity studies have been performed mostly using cell markers to distinguish 
cells.  Cell surface markers cannot fully represent the properties and behaviors of a cell, 
but FACS and MACS sorting are the only reliable methods to provide high throughput 
(~million cells per hour) cell characterization for cell heterogeneity studies.  
In this thesis, we demonstrated the capability to separate cells based on different 
motility, and the laser-based cell retrieval tool is a more general approach for retrieving 
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single cells based on their morphologies. The sorted cells were proved to have different 
mRNA expressions and behaviors, verifying the feasibility of sorting cells by behavior 
rather than markers. However, low throughput (less than 100 cells can be retrieved per 
hour) hinders the use of these approaches on a large scale or as a replacement for FACS 
and MACS.  Moving toward the behavior-based cell sorter, we should improve the 
throughput by implementing high-throughput imaging capabilities, fully automatic 
software analysis, and robotic automation of liquid handling. Though throughput of 
behavior based sorted will be still significantly lower than that of the conventional FACS 
sorter, the ability of our platforms to handle small samples with high efficiency will 
alleviate the need for high-throughput. Combining behavior based cell sorter and the 
capability of analyzing small samples can change the paradigm of cell heterogeneity 
studies.  
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